Pierre Marquet

Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship, Woillard, J. B., Marquet, P., Venat-Bouvet, L., Tubiana-Mathieu, N., Laroche, M. L., Picard, N., Monchaud, C., Saint-Marcoux, F., Falkowski, S., Deppenweiler, M., Pharmacological Research, 2017, 10.1016/j.phrs.2017.04.029

Population pharmacokinetic/pharmacogenetic modeling and design of a bayesian estimator for the therapeutic drug monitoring of tacrolimus in lung transplantation, Rousseau, A., Marquet, P., Guillemain, R., Kessler, R., Stern, M., Pison, C., Reynaud-Gaubert, M., Estenne, M., De Winter, B., Monchaud, C., Fundamental & Clinical Pharmacology, 2011

Pharmacokinetic modelling and development of Bayesian estimators for the therapeutic drug monitoring of Mycophenolate mofetil in non myeloablative haematopoietic cell transplantation, Marquet, P., Deconinck, E., Legrand, F., Larosa, F., Debord, J., Royer, B., Saini-Marcoux, F., Fundamental & Clinical Pharmacology, 2008

A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits, Godin, Michel, Hellot, Marie-France, Francois, Arnaud, Marquet, Pierre, Westeel, Pierre-Francois, Le Meur, Yannick, de Ligny, Bruno Hurault, Al Najjar, Azmi, Thierry, Antoine, Benichou, Jacques, Toupance, Olivier, Etienne, Isabelle, Nephrology Dialysis Transplantation, 2010, 10.1093/ndt/gfq135

Fatal intoxication following self-administration of a massive dose of buprenorphine, Lachatre, G, Dupuy, JL, Lacassie, E, Marquet, P, Gaulier, JM, Journal of Forensic Sciences, 2000

Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions, Estenne, M, Marquet, P, Rousseau, A, Saint-Marcoux, F, Thiry, P, Knoop, C, American Journal of Transplantation, 2005, 10.1111/j.1600-6143.2005.00870.x

PK Modelling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving Once-Daily Tacrolimus (ADVAGRAF)., Marquet, Pierre, Undre, Nasrullah, Debord, Jean, Saint-Marcoux, Franck, American Journal of Transplantation, 2009

NEUROTOXICITY OF TACROLIMUS IN RENAL TRANSPLANT PATIENTS: RELATIONSHIP BETWEEN TREMOR AND EXPOSURE TO TACROLIMUS, Marquet, Pierre, Monchaud, Caroline, Buchler, Matthias, Etienne, Isabelle, Westeel, Pierre-Francois, Rostaing, Lionel, Kamar, Nassim, Merville, Pierre, Lacroix, Isabelle, Bouchet, Stephane, Coubret, Anne, Laroche, Marie-Laure, Essig, Marie, Berthier, Joseph, Transplant International, 2015

Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles, Pierre Marquet, Jean Debord, Jean‐Baptiste Woillard, Marc Labriffe, CPT: Pharmacometrics & Systems Pharmacology, 2022, 10.1002/psp4.12810

Effect of Mycophenolate Acyl-Glucuronide on Human Recombinant Type 2 Inosine Monophosphate Dehydrogenase, Marquet, Pierre, Picard, Nicolas, Gensburger, Olivier, Clinical Chemistry, 2009, 10.1373/clinchem.2008.113936

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs, Marquet, P, Therapeutic Drug Monitoring, 2005, 10.1097/01.ftd.0000179848.65266.aa

Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry, Saint-Marcoux, F., Marquet, P., El Balkhi, S., Moreau, S., Baumgarten, S., Loftus, N., Dulaurent, S., Barnes, A., Robin, T., Analytical and Bioanalytical Chemistry, 2018, 10.1007/s00216-018-1159-7

UTERUS TOLERANCE TO LONG-TIME COLD ISCHEMIC STORAGE AFTER AUTO-TRANSPLANTATION IN EWE, Gauthier, T., Piccardo, A., Marquet, P., Terro, F., Yardin, C., Couquet, C., Lachatre, D., Mesturoux, L., Tholance, Y., Ponsonnard, S., Tricard, J., Transplant International, 2016

FP7 BIOMARGIN SHOWS THAT A SMALL SET OF BLOOD MICRO-RNAS IS ASSOCIATED WITH ACUTE KIDNEY ALLOGRAFTS REJECTION, Anglicheau, D., Marquet, P., Essig, M., Gwinner, W., Naesens, M., Gazut, S., Benon, A., Tinel, C., Transplant International, 2018

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy, , Therapeutic Drug Monitoring, 2019, 10.1097/ftd.0000000000000640

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C, Vidal, Elisabeth, Liozon, Eric, Fauchais, Anne-Laure, Lefebvre, Annie, Cales, Paul, Lunel, Francoise, Denis, Francois, Marquet, Pierre, Sauvage, Francois Ludovic, Hubert, Isabelle Fouchard, Rousseau, Annick, Alain, Sophie, Loustaud-Ratti, Veronique, Hepatology, 2008, 10.1002/hep.22217

Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case report., Woillard JB, Saint-Marcoux F, Marquet P, Couderc S, Picard N, Monchaud C, El Balkhi S, Dulaurent S, Franck B, British journal of clinical pharmacology, 2018, 10.1111/bcp.13790

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele, Le Meur, Yann, Marquet, Pierre, Essig, Marie, Munteanu, Eliza, Drouet, Mireille, Rousseau, Annick, Picard, Nicolas, Rerolle, Jean-Philippe, Woillard, Jean-Baptiste, British Journal of Clinical Pharmacology, 2010, 10.1111/j.1365-2125.2010.03625.x

Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis, Lachatre, G, Merle, L, Treves, R, Marquet, P, Bertin, P, Sabot, C, Carpentier, N, Debord, J, International Journal of Clinical Pharmacology and Therapeutics, 1998

Influence of metabolic enzymes and efflux transporter polymorphisms on the plasma concentrations of MPA metabolites in renal transplant recipients., Rousseau, A, Szelag, JC, Le Meur, Y, Picard, N, Djebli, N, Marquet, P, American Journal of Transplantation, 2005

Population pharmacokinetics of ganciclovir and valganciclovir in paediatric solid organ and stem cell transplant recipients., , British journal of clinical pharmacology, 2020, 10.1111/bcp.14719

Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil, Marquet, Pierre, Van Gelder, Teun, Woillard, Jean-Baptiste, Rousseau, Annick, Le Meur, Yannick, Picard, Nicolas, Van Schaik, Ron H. N., Gensburger, Olivier, Pharmacogenetics and Genomics, 2010, 10.1097/FPC.0b013e32833d8cf5

A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry, Lachatre, G, Dupuy, JL, Duchoslav, E, Marquet, P, Venisse, N, Journal of Analytical Toxicology, 2003

CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients, Marquet, Pierre, Rostaing, Lionel, Kamar, Nassim, Rouguieg-Malki, Koukeb, Picard, Nicolas, Transplantation, 2011, 10.1097/TP.0b013e31820ae4ac

Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies, Lechat, Philippe, Piette, Jean Charles, Marquet, Pierre, Saint-Marcoux, Franck, Hulot, Jean-Sebastien, Debord, Jean, Amoura, Zahir, Zahr, Noeel, Clinical Pharmacokinetics, 2008

PHARMACOKINETICS OF VINORELBINE IN MAN, NICOT, G, BONNAUD, F, EICHLER, B, DEBORD, J, LACHATRE, G, MARQUET, P, European Journal of Clinical Pharmacology, 1992, 10.1007/BF00314866

Overview of accessibility and quality of antiepileptic drugs in Madagascar, Ratsimbazafy, Voa, Preux, Pierre-Marie, Marquet, Pierre, Solofomalala, Gaetan Duval, Megherbi, Mehdi, Andriambololona, Rindra, Tanamasoandro, Rakotovao, Jost, Jeremy, Nizard, Mandy, Seizure-European Journal of Epilepsy, 2016, 10.1016/j.seizure.2016.07.015

Effects of dexamethasone on adrenal steroid plasma levels in healthy subjects at work, Habrioux, G, Galen, FX, Chassain, AP, Marquet, P, Egloff, M, Lafarge, P, Science & Sports, 1997, 10.1016/S0765-1597(97)80691-0

The apoptosis-inducing toxin Brefeldin A is taken up and secondarily released by neurons, Hugon, J, Esclaire, F, Marquet, P, Terro, F, Yardin, C, Neuroscience Research Communications, 2000, 10.1002/1520-6769(200009/10)27:2<125::AID-NRC6>3.0.CO;2-0

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?, Hellemans R, Abramowicz D, Massart A, Monchaud C, Marquet P, Wouters K, Roosens L, Haverals L, Transplantation direct, 2023, 10.1097/txd.0000000000001439

A LC-MS/MS Method for the Simultaneous Evaluation of Human Glucuronidation Enzyme Activities using an in vitro Cocktail Approach, Marquet, P., Sauvage, F-L., Picard, N., Rouguieg, K., Therapeutic Drug Monitoring, 2009

Mycophenolic Acid Glucuronides Pharmacologically Active on Inosine MonoPhophate DeHydrogenase Type II (IMPDH II)?, Marquet, P., Picard, N., Gensburger, O., Therapeutic Drug Monitoring, 2009

Genetic polymorphisms of the calcineurin pathway and their implication in renal transplant patient outcomes, Picard, N., Marquet, P., Petersen, B., Le Meur, Y., Bouchet, S., Gandia, P., Merville, P., Kamar, N., Essig, M., Monchaud, C., Stojanova, J., Villeneuve, C., Woillard, J., Koikta, M., Pouche, L., Fundamental & Clinical Pharmacology, 2015

Cyclosporine monitoring in renal transplant recipients with induction therapy: C-2 levels in patients monitored on C-0, French Pharmacological Soc, Marquet, P, Simon, N, Peytavin, G, Paintaud, G, Kergueris, MF, Boulieu, R, Bonardet, A, Bernard, N, Bentue-Ferrer, D, Loichot, C, Fundamental & Clinical Pharmacology, 2006, 10.1111/j.1472-8206.2005.00383.x

Immunosuppressant dosing accuracy. Residual drug concentration versus estimation of the area under the curve, Stankevicius, E., Kadusevicius, E., Woillard, J. B., Marquet, P., Saint-Marcoux, F., Noreikaite, A., Acta Physiologica, 2017

Metabolic pathways involved in the activation of organophosphothioate pesticides, Marquet, P, Lachatre, G, Dulaurent, S, Picard, N, Teilhet, E, Therapeutic Drug Monitoring, 2005

Effect of a new functional CYP3A4 polymorphism on sirolimus in vitro metabolism and kidney transplant recipients trough levels, Picard, N., Marquet, P., Coste, S., Rostaing, L., Kamar, N., Woillard, J. B., Fundamental & Clinical Pharmacology, 2012

Decrease of serum paraoxonase activity with age and in chronic renal failure: Relationship with coronary heart disease, Leroux-Robert, C, Merle, L, Lachatre, G, Marquet, P, Charmes, JP, Debord, J, Dantoine, TF, Circulation, 1998

EVALUATING PATIENTS' PERCEPTION OF THEIR IMMUNOSUPPRESSIVE TREATMENT: A SIMPLE TOOL TO ENHANCE PATIENT ADHERENCE, Monchaud, C., Marquet, P., Loustaud-Ratti, V., Bert, K., Bonneau, A., Cleret, S., Dussoulier, I., Debette-Gratien, M., Grau, M., Villeneuve, C., Transplant International, 2017

Special issue - 40th Annual International Meeting of the International Association of Forensic Toxicologists - Preface, Organising Comm, Kintz, P, Marquet, P, Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2003, 10.1016/S1570-0232(03)00136-3

Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: Method with forensic applications, Marquet, Pierre, Lachatre, Gerard, Gaulier, Jean-Michel, Charvier, Fabienne, Sauvage, Francois-Ludovic, Quintela, Oscar, Clinical Chemistry, 2006, 10.1373/clinchem.2005.065631

Mechanisms underlying postmortem redistribution of drugs: A review, Marquet, P, Champsaur, P, Gaulier, JM, Pelissier-Alicot, AL, Journal of Analytical Toxicology, 2003

Low alfentanil target-concentrations improve hemodynamic and intubating conditions during induction with sevoflurane, Feiss, P, Preux, PM, Marquet, P, Benrhaiem, M, Vandroux, D, Nathan, N, Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie, 2004

FP7 BIOMARGIN SHOWS THAT SMALL SETS OF URINARY PEPTIDES ARE GOOD BIOMARKERS OF ACUTE KIDNEY GRAFT REJECTION, Marquet, P., Essig, M., Mihatsch, M., Brocheriou, I., Noel, L. H., Gwinner, W., Anglicheau, D., Naesens, M., Woillard, J. B., Sauvage, F. L., Transplant International, 2017

Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients., , Progress in transplantation (Aliso Viejo, Calif.), 2019, 10.1177/1526924819873905

Early dose adjustment of RBV in HCV patients treated with peginterferon and RBV is efficient and safe in the population underexposed to the drug. Multicentric French Study (Ribajuste), Trepo, Christian, Marquet, Pierre, Zublena, Irene, Picard, Nicolas, Lunel-Fabiani, Francoise, Deny, Paul, Alain, Sophie, Gagnieu, Marie-Claude, Rousseau, Annick, Pradat, Pierre, Thevenon, Sylvie, Maynard-Muet, Marianne, Loustaud-Ratti, Veronique, Hepatology, 2015

Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets?, Hauet, T., Marquet, P., Bon, D., Largeau, B., Barin-Le Guellec, C., Pharmacological Research, 2018, 10.1016/j.phrs.2017.12.032

Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition, Marquet, P., Woillard, J. B., Gerona, S., Tourino, C., Vital, M., Lens, D., Esperon, P., Pouche, L., Noceti, O., Clinical Chemistry, 2017, 10.1373/clinchem.2017.272534

Effect of calcineurine and mTOR inhibitors on the intestinal absorption of mycophenolic acid, Marquet, Pierre, Sauvage, Francois-Ludovic, Picard, Nicolas, Boussera, Belkacem, Therapeutic Drug Monitoring, 2007

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation, Marquet, P., Touchard, G., Rousseau, A., Rerolle, J.-P., Szelag, J. C., Thervet, E., Rostaing, L., de Ligny, B. H., Westeel, P.-F., Etienne, I., Lavaud, S., Villemain, F., Caillard, S., Thierry, A., Buechler, M., Le Meur, Y., American Journal of Transplantation, 2007, 10.1111/j.1600-6143.2007.01983.x

COMPARISON OF 2-COMPARTMENT AND 3-COMPARTMENT MODELS FOR THE BAYESIAN-ESTIMATION OF METHOTREXATE PHARMACOKINETICS, LACHATRE, G, MERLE, L, MARQUET, P, ROULLET, B, SABOT, C, DEBORD, J, International Journal of Clinical Pharmacology and Therapeutics, 1995

How to predict clinical outcome in kidney transplantation? A dynamic, early marker of long-term graft survival, Rousseau, A., Marquet, P., Munteanu, E., Woillard, J. B., Essig, M., Abdi, Daher Z., Therapeutic Drug Monitoring, 2011

Influence of MRP2 (C-24T) SNP on MPA-to-metabolites plasma ratios in renal transplant recipients, Marquet, P, Rousseau, A, Szelag, JC, Picard, N, Le Meur, Y, Djebli, N, Therapeutic Drug Monitoring, 2005

Quantitative proteomic analysis of CSA-induced toxicity in renal cells reveals the perturbation of multiple cellular pathways, Marquet, P., Gastinel, L., Lamoureux, F., Essig, M., Fundamental & Clinical Pharmacology, 2011

Buprenorphine and pregnancy - A comparative, multicenter clinical study of high-dose buprenorphine vs methadone maintenance, Marquet, P, Kintz, P, Piquet, M, Cneude, F, Simmat-Durand, L, Aubisson, S, Lejeune, C, Buprenorphine Therapy of Opiate Addiction, 2002

Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones, Galen, FX, Habrioux, G, Chassain, AP, Lac, G, Marquet, P, Journal of Applied Physiology, 1999

On the proportional abundance of species: Integrating population genetics and community ecology., Rebolledo R, Ganz A, Abades SR, Espinoza G, Marquet PA, Scientific reports, 2017, 10.1038/s41598-017-17070-1

Uterine transplantation: Is there a real demand?, Aubard, Y., Marquet, P., Pichon, N., Essig, M., Piver, P., Therme, J. -F., Garnault, D., Gauthier, T., Gynecologie Obstetrique & Fertilite, 2015, 10.1016/j.gyobfe.2014.12.005

Pharmacokinetic study of mycophenolate mofetil and design of a Bayesian estimator based on a limited sampling strategy in patients with systemic lupus erythematosus, Lechat, P., Piette, J. C., Marquet, P., Saint-Marcoux, F., Hulot, J. S., Amoura, Z., Debord, J., Zahr, N., Fundamental & Clinical Pharmacology, 2007

Pharmacology of opiates during pregnancy and in neonates, Kintz, P, Marquet, P, Buprenorphine Therapy of Opiate Addiction, 2002

New Tools for Mycophenolate Mofetil (MMF) Dose Optimization in Heart and/or Lung Transplant Recipients during the First Year Post-Transplant: Preliminary Results of the PIGREC and STIMMUGREP Trials, Marquet, Pierre, Stern, Marc, Sebbag, Laurent, Redonnet, Michel, Kessler, Romain, Dromer, Claire, Rolle, Florence, Saint-Marcoux, Franck, American Journal of Transplantation, 2010

Development of a Population Pharmacokinetic model and a Bayesian Estimator for estimation of Everolimus Whole Blood and Intra-lymphocyte Exposure in Renal Transplant Recipients, Robertsen, I., Marquet, P., Asberg, A., Debord, J., Woillard, J. B., Fundamental & Clinical Pharmacology, 2018

Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy, Paintaud, G, Marquet, P, Lebranchu, Y, Gakoue, JE, Le Meur, Y, Giraudeau, B, Buchler, M, Le Guellec, C, European Journal of Clinical Pharmacology, 2002, 10.1007/s00228-001-0389-2

Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?, Marquet, P, Therapeutic Drug Monitoring, 2002, 10.1097/00007691-200202000-00020

Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside., , International journal of cancer, 2019, 10.1002/ijc.32533

Pharmacological & pharmacogenetic factors in post-transplant lymphoproliferative disease: feasibility of matching in a case-control study, Marquet, P., Essig, M., Rerolle, J. P., Roussel, H., Rousseau, A., Caillard, S., Stojanova, J., Therapeutic Drug Monitoring, 2011

Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients., Marquet P, Debord J, Saint-Marcoux F, Monchaud C, Woillard JB, Micallef L, Labriffe M, Therapeutic drug monitoring, 2023, 10.1097/ftd.0000000000001087

Toxicity of tungsten - Reply, Lachatre, G, Vignon, P, Francois, B, Marquet, P, Lancet, 1997, 10.1016/S0140-6736(05)62195-2

Influence of UGT1A9*3 and UGT2B7 (G-840A) polymorphisms on MPA metabolism in renal transplant recipients, Marquet, P, Rousseau, A, Szelag, JC, Le Meur, Y, Picard, N, Djebli, N, Therapeutic Drug Monitoring, 2005, 10.1097/00007691-200504000-00154

A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients, Le Meur, Yannick, Marquet, Pierre, Rousseau, Annick, Premaud, Aurelie, Picard, Nicolas, British Journal of Clinical Pharmacology, 2006, 10.1111/j.1365-2125.2006.02509.x

Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography-electrospray mass spectrometry, Lachatre, G, Francois, B, Dupuy, JL, Lacassie, E, Gaulier, JM, Baudin, O, Marquet, P, Journal of Chromatography B, 1999, 10.1016/S0378-4347(99)00340-0

Translational Research: Precision Medicine, Personalized Medicine, Targeted Therapies: Marketing or Science?, Verstuyft, Celine, Tisseau, Anne, Pigeon, Martine, Perin-Dureau, Florent, Perche, Olivier, Morin-Surroca, Michele, Mourah, Samia, Hoog-Labouret, Natalie, Gueyffier, Francois, Goni, Sylvia, Froguel, Philippe, Divine, Marine, Diaz, Isabelle, Chatelue, Etienne, Cazeneuve, Beatrice, Auge, Pascale, Ameye, Veronique, Barlesi, Fabrice, Longeray, Pierre-Henry, Marquet, Pierre, Therapie, 2015, 10.2515/therapie/2014231

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation, Elens, L., Haufroid, V., Marquet, P., Hesselink, D. A., Lloberas, N., van Gelder, T., van Schaik, R. H., Capron, A., Neely, M., Mourad, M., Woillard, J. B., Frontiers in Pharmacology, 2017, 10.3389/fphar.2017.00358

Controlled drug administration studies of high-dose buprenorphine in humans, Marquet, P, Kintz, P, Huestis, MA, Buprenorphine Therapy of Opiate Addiction, 2002

Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships, Kamar, Nassim, Marquet, Pierre, Rostaing, Lionel, Peron, Jean Marie, Muscari, Fabrice, Gandia, Peggy, Canivet, Cindy, Johnson, Gyasi, Rousseau, Annick, Premaud, Aurelie, Pharmacological Research, 2011, 10.1016/j.phrs.2011.01.005

Ganciclovir and its metabolites optimized pharmacokinetic modelling for exposure-effect in adult renal transplant recipients, Saint-Marcoux, F., Picard, N., Marquet, P., Essig, M., Sauvage, F. L., Woillard, J. B., Billat, P. A., Fundamental & Clinical Pharmacology, 2015

A Machine Learning Approach to Estimate the Glomerular Filtration Rate in Intensive Care Unit Patients Based on Plasma Iohexol Concentrations and Covariates., , Clinical pharmacokinetics, 2021, 10.1007/s40262-020-00927-6

Population Pharmacokinetics (popPK) of Capecitabine in Elderly Patients With Colorectal or Breast Cancer, Tubiana-Mathieu, N., Rousseau, A., Marquet, P., Woillard, J. B., Leobon, S., Martin, J., Urien, S., Sauvage, F. L., Lavau-Denes, S., Abdi, Z. Daher, Therapeutic Drug Monitoring, 2013

A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney Transplantation, , Journal of Transplantation, 2019, 10.1155/2019/7245142

Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes, Florent Di Meo, Pierre Marquet, Chantal Barin-Le Guellec, Benjamin Chantemargue, Marving Martin, Quentin Faucher, Ágota Tóth, Angelika Janaszkiewicz, 2022, 10.1101/2022.01.10.475390

Towards therapeutic drug monitoring of mycophenolic acid in cicatricial pemphigoid patients, Bedane, C., Marquet, P., Assikar, S., Saint-Marcoux, F., Monchaud, C., Roussel, H., Maffioletti, P. F., Woillard, J. B., Fundamental & Clinical Pharmacology, 2017

Buprehorphine as a viable pharmacotherapy is Australia, Marquet, P, Kintz, P, Lewis, JH, Buprenorphine Therapy of Opiate Addiction, 2002

Real life experience of mycophenolate mofetil monotherapy in liver transplant patients., , Clinics and research in hepatology and gastroenterology, 2020, 10.1016/j.clinre.2020.04.017

Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients, Rousseau, Annick, Le Meur, Yann, Thiry, Philippe, Bernard, Nicole, Jacqz-Aigrain, Evelyne, Marquet, Pierre, Saint-Marcoux, Franck, Clinical Pharmacokinetics, 2006, 10.2165/00003088-200645090-00003

Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After Transplantation, EPIGREN Study Grp, Rousseau, Annick, Marquet, Pierre, Fruit, Dorothee, Bouchet, Stephane, Lacroix, Isabelle, Coubret, Anne, Kamar, Nassim, Merville, Pierre, Essig, Marie, Laroche, Marie-Laure, Villeneuve, Claire, Transplantation, 2016, 10.1097/TP.0000000000000846

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients., , Kidney international reports, 2020, 10.1016/j.ekir.2020.06.018

FP7 BIOMARGIN SHOWS THAT SMALL SETS OF INTRA-GRAFT MICRORNAS ARE STRONGLY ASSOCIATED WITH RENAL ALLOGRAFT LESIONS, Anglicheau, D., Marquet, P., Essig, M., Gwinner, W., Naesens, M., Gazut, S., Benon, A., Tinel, C., Transplant International, 2018

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry, Gastinel, L. N., Le Meur, Y., Rerolle, J. P., Marquet, P., Benkali, K., Bmc Genomics, 2008, 10.1186/1471-2164-9-541

Perfusate metabolomics content and tubular transporters expression during kidney graft preservation by hypothermic machine perfusion, Guellec CB, Marquet P, Bruyère F, Brichart N, Venhard J, Arnion H, Nadal-Desbarats L, Miquelestorena-Standley E, Forestier L, Sauvage F, Alarcan H, Faucher Q, 2021, 10.1101/2021.09.27.21264167

HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF NAVELBINE IN HUMAN PLASMA AND URINE, ROCCA, JL, VALLETTE, JP, BONNAUD, F, MARQUET, P, LACHATRE, G, NICOT, G, Journal of Chromatography-Biomedical Applications, 1990, 10.1016/S0378-4347(00)82384-1

PHARMACOEPIDEMIOLOGICAL STUDY IN RENAL TRANSPLANTATION: COMPARISON OF DIFFERENT TOOLS FOR THE COLLECTION OF DATA ON TREATMENTS, SIDE EFFECTS AND COMPLIANCE., Essig, M., Rostaing, L., Laroche, M., Montastruc, J., Moore, N., Kamar, N., Merville, P., Marquet, P., Clinical Pharmacology & Therapeutics, 2010

Post-mortem redistribution of three beta-blockers in the rabbit, Marquet, P, Lachatre, G, Leonetti, G, Feuerstein, M, Dupuis, C, Gaulier, JM, Pelissier-Alicot, AL, International Journal of Legal Medicine, 2006, 10.1007/s00414-005-0022-5

Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients, Cassuto, E., Thervet, E., Charpentier, B., Buchler, M., Gatault, P., Sakarovitch, C., Kamar, N., Rostaing, L., Woillard, J. B., Albano, L., Marquet, P., Pharmacological Research, 2018, 10.1016/j.phrs.2017.12.005

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations in adult liver transplant patients, , British Journal of Clinical Pharmacology, 2019, 10.1111/bcp.13960

Therapeutic Drug Monitoring in the Era of Precision Medicine: Achievements, Gaps, and Perspectives-An Interview in Honor of Professor Charles Pippenger., Shipkova M, Vinks AA, Walson P, Bergan S, Svinarov D, Cattaneo D, Marquet P, Wong SH, Therapeutic drug monitoring, 2021, 10.1097/ftd.0000000000000932

Voriconazole clearance estimation using pharmacokinetic population modeling, Woillard, J. B., Gandia, P., Marquet, P., Seraissol, P., Laffont, M. A., Lamoureux, F., Metsu, D., Fundamental & Clinical Pharmacology, 2015

Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis, Marquet, Pierre, Lachatre, Gerard, Gaulier, Jean-Michel, Sauvage, Francois-Ludovic, Clinical Chemistry, 2008, 10.1373/clinchem.2008.105478

Mass spectrometry platform in Limousin, Marquet, P., Gastinel, L. N., Bulletin Du Cancer, 2008

High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation., , Communications biology, 2021, 10.1038/s42003-021-01989-3

High-performance liquid chromatographic determination of tianeptine in plasma applied to pharmacokinetic studies, Lachatre, G, Desroches, R, Lacassie, E, Marquet, P, Gaulier, JM, Journal of Chromatography B, 2000, 10.1016/S0378-4347(00)00368-6

Modeling of the Exposure to Tacrolimus in Kidney Transplantation, Aouam, K., Saint-marcoux, F., Marquet, P., Boughattas, N., Ben Fadhel, N., Chadly, Z., Chaabane, A., Debord, J., Woillard, J. B., Ben Fredj, N., Therapeutic Drug Monitoring, 2013

A new insight in loratadine metabolism in human using LC-MS/MS detection and characterization, Marquet, Pierre, Bouehanas, Naceur A., Sauvage, Francois-Ludovic, Picard, Nicolas, Dridi, Dorra, Therapeutic Drug Monitoring, 2007

Steroid-free regimen and optimization of mycophenolic acid (MPA) exposure in liver transplant recipients: final results of a randomized multicenter trial, Rostaing, Lionel, Tagieva, Naila, Duer, Carole, Sebagh, Mylene, Marquet, Pierre, Vanlemmens, Claire, Hardwigsen, Jean, Dharancy, Sebastien, Pageaux, Georges-Philippe, Duvoux, Christophe, Altieri, Mario, Calmus, Yvon, Neau-Cransac, Martine, Leroy, Vincent, Radenne, Sylvie, Gugenheim, Jean, Durand, Francois, Saliba, Faouzi, Hepatology, 2012

Multiresidue determination of pesticides in apples and pears by gas chromatography mass spectrometry, Lachatre, G, Marquet, P, Vignaud, M, Daguet, JL, Dreyfuss, MF, Lacassie, E, Journal of Chromatography a, 1998, 10.1016/S0021-9673(97)01305-8

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation, Oellerich, Michael, Wallemacq, Pierre, Pawinski, Tomasz, Noceti, Ofelia, Hesselink, Dennis A., Marquet, Pierre, Millan Lopez, Olga, Picard, Nicolas, Bergan, Stein, Barten, Markus J., Lopez-Hoyos, Marcos, Christians, Uwe, Haufroid, Vincent, Budde, Klemens, Sommerer, Claudia, Wieland, Eberhard, van Gelder, Teun, Shipkova, Maria, Brunet, Merce, Therapeutic Drug Monitoring, 2016

Advagraf (R) Pharmacokinetics Analysis in Stable Renal Transplant Patients., Rostaing, Lionel, Rousseau, Annick, Marquet, Pierre, Premaud, Aurelie, Kamar, Nassim, Benkali, Khaled, American Journal of Transplantation, 2009

The Key Role of Warm and Cold Ischemia in Uterus Transplantation: A Review., , Journal of clinical medicine, 2019, 10.3390/jcm8060760

BLOOD LACTATE LEVELS IN THE RACE HORSE - SEQUENCES OF INCREMENTAL AND CONSTANT-LOAD SHORT-TERM RUNS, VALADE, M, DALMAY, F, MARQUET, P, VILLENEUVE, P, NICOLAS, A, ANTONINI, MT, BLANC, P, DAURIAC, E, CHASSAIN, AP, Archives Internationales De Physiologie De Biochimie Et De Biophysique, 1992, 10.3109/13813459209000728

Polymorphisms in donor P-gp influence renal function and graft loss in a long term cohort of renal transplant recipients, Marquet, P., Le Meur, Y., Drouet, M., Essig, M., Munteanu, E., Rousseau, A., Picard, N., Rerolle, J-P, Woillard, J-B, Fundamental & Clinical Pharmacology, 2010

Limited sampling strategy for the estimation of mycophenolate AUC: A large scale study, Marquet, P, Rousseau, A, Le Meur, Y, Premaud, A, Therapeutic Drug Monitoring, 2003

Population Pharmacokinetic Model and Bayesian Estimator for Mycophenolate Mofetil (MMF) in Lung Transplantation, Rousseau, A., Estenne, M., Knoop, C., Guillemain, R., Stern, M., Dromer, C., Reynaud-Gaubert, M., Kessler, R., Pison, C., Premaud, A., Monchaud, C., de Winter, B. C. M., Marquet, P., American Journal of Transplantation, 2011

Intravenous induction of acute arsenic poisoning, Leonetti, G, Panteix, G, Marquet, P, Salerio, G, Pelissier-Alicot, AL, Presse Medicale, 2003

Pharmacodynamic Monitoring of mTOR Inhibitors, , Therapeutic Drug Monitoring, 2019, 10.1097/ftd.0000000000000616

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Mourad, Michel, Westley, Ian S., Weber, Lutz T., Undre, Nas, Toenshoff, Burkhand, Thervet, Eric, Oellerich, Michael, Marquet, Pierre, Le Meur, Yannick, Kuypers, Dirk, Johnston, Atholl, Holt, David W., Haufroid, Vincent, Brunet, Merce, Armstrong, Victor W., Wallemacq, Pierre, Therapeutic Drug Monitoring, 2009

Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation, MPA, van Gelder, Teun, Chapman, Jeremy, Holt, David W., Toenshoff, Burkhard, Cattaneo, Dario, Tett, Susan E., Tredger, Michael J., Cantarovich, Marcelo, Le Meur, Yannick, Kuypers, Dirk R. J., Clinical Journal of the American Society of Nephrology, 2010, 10.2215/CJN.07111009

Cyclosporin proficiency testing program: summary and analysis of french laboratories' results, Vassault, A, Holt, DW, Johnston, A, Meninat, F, Billaud, E, Perrin, A, Marquet, P, Annales De Biologie Clinique, 1999

In-vivo and in-vitro study of cyclosporin and Sirolimus pharmacokinetic interactions with mycophenolate mofetil, Marquet, P, Rousseau, A, Szelag, JC, Toupance, O, Le Meur, Y, Hoizey, G, Picard, N, Therapeutic Drug Monitoring, 2005

Endogenous metabolites-mediated communication between OAT1/OAT3 and OATP1B1 may explain the association between SLCO1B1 SNPs and methotrexate toxicity, Andres, C., Marquet, P., Gyan, E., Choquet, S., Berthelot, A., Woillard, J. B., Martinez, D., Muhrez, K., Barin-Le Guellec, C., Fundamental & Clinical Pharmacology, 2018

Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?, Zins M, Mahfoudi A, Lyonnet S, Garbil B, Froguel P, Duluc G, Debette S, Boitard C, Beretz A, Benhabiles N, Le Jeunne C, Vacaresse E, Dantonel JC, Bordet R, Therapie, 2022, 10.1016/j.therap.2022.01.005

Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation., Woillard JB, Labriffe M, Monchaud C, van Hoek B, Rostaing L, Moes DJAR, Marquet P, Ponthier L, European journal of clinical pharmacology, 2022, 10.1007/s00228-022-03445-5

Improvement of Charcot-Marie-Tooth Phenotype with a Nanocomplex Treatment in Two Transgenic Models of CMT1A, Massry ME, Sturtz F, Sol V, Vallat J, Favreau F, Marquet P, Bregier F, Faye P, Pinault E, Richard L, Vignaud L, Ndong-Ntoutoume GM, Masri TE, Msheik Z, 2023, 10.21203/rs.3.rs-2786317/v1

Population pharmacokinetics and Bayesian estimator of cyclosporine in pediatric renal transplant patients, Jacqz-Aigrain, E., Marquet, P., Leroy, V., Zhang, D., Rousseau, A., Saint-Marcoux, F., Irtan, S., Therapeutic Drug Monitoring, 2007, 10.1097/FTD.0b013e3180310f9d

Fetal growth restriction, low birth weight, and preterm birth: Effects of active or passive smoking evaluated by maternal expired CO at delivery, impacts of cessation at different trimesters, Yves Aubard, Pierre Marquet, Tristan Gauthier, Amal Jamee, Michel-Henri Delcroix, Conchita Delcroix-Gomez, Tobacco Induced Diseases, 2022, 10.18332/tid/152111

Benefit of a 50% reduction of cyclosporine exposure in stable kidney transplant recipients treated with MMF without corticosteroids. the DICAM randomized study., Godin, M., Benichou, J., Hellot, M. F., Francois, A., Marquet, P., Westeel, P. F., Le Meur, Y., de Ligny, B. Hurault, Al Najjr, A., Thierry, A., Toupance, O., Etienne, I., American Journal of Transplantation, 2007

Sum of peak intensities outperforms peak area integration in iTRAQ protein expression measurement by LC-MS/MS using a TripleTOF 5600+ platform., , Bioscience Reports, 2019, 10.1042/bsr20190904

Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis, Prémaud A, Marquet P, Rousseau A, Woillard J, Nanga T, 2021, 10.22541/au.163577198.80163436/v1

Cyclosporine A (CsA): new perspectives for an old molecule, Marquet, P., Fundamental & Clinical Pharmacology, 2001

Bayesian Estimation of Mycophenolate Mofetil in Lung Transplantation, Using a Population Pharmacokinetic Model Developed in Kidney and Lung Transplant Recipients, Rousseau, Annick, Marquet, Pierre, Estenne, Marc, Knoop, Christiane, Guillemain, Romain, Stern, Marc, Dromer, Claire, Reynaud-Gaubert, Martine, Kessler, Romain, Pison, Christophe, Premaud, Aurelie, Monchaud, Caroline, de Winter, Brenda C. M., Clinical Pharmacokinetics, 2012

Epigenetic research in pharmacology: perspectives and pitfalls, Picard, N., Marquet, P., Gonzalez, J., Pouche, L., Lebreton, V., Fundamental & Clinical Pharmacology, 2015

Professor Folke Sjöqvist peacefully passed away on March 30, 2020., , European journal of clinical pharmacology, 2020, 10.1007/s00228-020-02911-2

Urinary collagen-derived peptides as sensitive markers for bone resorption and bisphosphonate treatment in kidney transplant patients, Metzger J, Gwinner W, Perrin P, Marquet P, Prié D, Bienaimé F, Latosinska A, Pejchinowski M, Mischak H, Kochman A, Moulin B, Caillard S, Anglicheau D, Marx D, 2022, 10.1101/2022.02.15.22270979

The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method., , European journal of clinical pharmacology, 2020, 10.1007/s00228-020-03044-2

Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5, Marquet, Pierre, Sauvage, Francois-Ludovic, Djebli, Nassim, Picard, Nicolas, Drug Metabolism and Disposition, 2007, 10.1124/dmd.106.012161

Influence of MRP2 Haplotype on MPA Exposure in Kidney Transplant Patients, Picard, N., Marquet, P., Rousseau, A., Levoir, L., Woillard, J. B., Therapeutic Drug Monitoring, 2009

Clinical and in-vitro study of the pharmacokinetic interactions of cyclosporin and sirolimus with mycophenolate mofetil., Rousseau, A, Szelag, JC, Toupance, O, Le Meur, Y, Hoizey, G, Picard, N, Marquet, P, American Journal of Transplantation, 2005

Decrease of serum paraoxonase activity in chronic renal failure and return to normal values after transplantation, Ardaillou, R, LerouxRobert, C, Merle, L, Lachatre, G, Marquet, P, Charmes, JP, Debord, J, Dantoine, T, Journal of the American Society of Nephrology, 1996

Everolimus population pharmacokinetics and Bayesian estimators when associated to low-dose cyclosporine in kidney and heart transplantation, Marquet, Pierre, Rousseau, Annick, Debord, Jean, Saint-Marcoux, Franck, Therapeutic Drug Monitoring, 2007

How has the future investment program stimulated research and innovation in health?, Zins M, Mahfoudi A, Lyonnet S, Garbil B, Froguel P, Duluc G, Debette S, Boitard C, Beretz A, Benhabiles N, Le Jeunne C, Vacaresse E, Dantonel JC, Bordet R, Therapie, 2022, 10.1016/j.therap.2022.01.009

Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches., , Transplantation, 2016, 10.1097/tp.0000000000001321

Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration, Raby, C, Lachatre, G, Buxeraud, J, Sauvage, MF, Lagorce, JF, Marquet, P, Rousseau, A, Pharmacology, 1998, 10.1159/000028248

Ingestion of high-dose buprenorphine by a 4 year-old child, Lachatre, G, Marquet, P, Monceaux, F, Charvier, F, Gaulier, JM, Journal of Toxicology-Clinical Toxicology, 2004, 10.1081/CLT-200042470

Plasma and intracellular exposure to ganciclovir in adult renal transplant recipients: is there an association with haematological toxicity?, Saint-Marcoux, Franck, Marquet, Pierre, Neely, Michael, Alain, Sophie, Picard, Nicolas, Sauvage, Francois-Ludovic, Essig, Marie, Woillard, Jean-Baptiste, Billat, Pierre-Andre, Journal of Antimicrobial Chemotherapy, 2016, 10.1093/jac/dkv342

Ex-vivo pharmacodynamics of tacrolimus on the calcineurin pathway of lymphocytes from healthy donors, Marquet, P., Esperon, P., Boumediene, A., Taupin, J. L., Noceti, O., Fundamental & Clinical Pharmacology, 2012

Advagraf((R)), a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts, Marquet, Pierre, Grimbert, Philippe, Audard, Vincent, Mariat, Christophe, Buron, Fanny, Moulin, Bruno, Caillard, Sophie, Transplant International, 2016, 10.1111/tri.12674

Special issue: TIAFT 2002 - Preface, Kintz, P, Marquet, P, Forensic Science International, 2003, 10.1016/S0379-0738(03)00041-0

Pharmacokinetic Optimization of Immunosuppressive Therapy in Thoracic Transplantation: Part I, Marquet, Pierre, Monchaud, Caroline, Clinical Pharmacokinetics, 2009

Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data, Pierre Marquet, Maarten Naesens, Priyanka Koshy, Marion Rabant, Dany Anglicheau, Jan-Hinrich Braesen, Wilfried Gwinner, Jean-Baptiste Woillard, Marc Labriffe, 2021, 10.1101/2021.09.17.21263552

Untargeted Screening of Urinary Peptides Using Offline Nano-Liquid Chromatography: MALDI-TOF/TOF Mass Spectrometry., Marquet P, Passeron S, Sauvage FL, Methods in molecular biology (Clifton, N.J.), 2018, 10.1007/7651_2017_74

Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus, Marquet, Pierre, Sauvage, Francois-Ludovic, Boussera, Belkacem, Picard, Nicolas, Lamoureux, Fabien, Fundamental & Clinical Pharmacology, 2012, 10.1111/j.1472-8206.2011.00957.x

Does CYP3A5 polymorphism influence everolimus intestinal and hepatic metabolism?, Marquet, P., Picard, N., Rouguieg-Malki, K., Fundamental & Clinical Pharmacology, 2010

Liquid chromatography-mass spectrometry: potential in forensic and clinical toxicology, Lachatre, G, Marquet, P, Journal of Chromatography B, 1999, 10.1016/S0378-4347(99)00147-4

Bupreuorphihe-related deaths, Marquet, P, Kintz, P, Buprenorphine Therapy of Opiate Addiction, 2002

Development of a Bayesian Estimator for Dose Optimization of Mycophenolate Mofetil (MMF, Cellcept) in Heart Transplant Recipients on MMF-Tacrolimus: Preliminary Results of the PIGREC Trial., Monchaud, C., Sinasse-Raymond, G., Epailly, E., Redonnet, M., Guillemain, R., Rolle, F., Sebbag, L., Kamar, N., Marquet, P., American Journal of Transplantation, 2011

Adaptive control methods for the dose individualisation of anticancer agents, Lachatre, G, Sabot, C, Debord, J, Marquet, P, Rousseau, A, Clinical Pharmacokinetics, 2000, 10.2165/00003088-200038040-00003

Joint modeling of longitudinal tacrolimus exposure in the first year post-LT and risk of renal failure: a new way to optimize target tacrolimus concentrations in the future, Premaud, Aurelie, Loustaud-Ratti, Veronique, Marquet, Pierre, Essig, Marie, Debette-Gratien, Maryline, Rousseau, Annick, Carrier, Paul, Hepatology, 2016

Large Scale Analysis of Routine Dose Adjustments of Mycophenolate Mofetil Based on Global Exposure in Renal Transplant Patients, Marquet, Pierre, Rousseau, Annick, Debord, Jean, Premaud, Aurelie, Vandierdonck, Soizic, Saint-Marcoux, Franck, Therapeutic Drug Monitoring, 2011, 10.1097/FTD.0b013e31821633a6

Tools for routine dose adjustment of mycophenolate mofetil based on MPA AUC Bayesian estimation: Experience with a new enzymatic assay, Marquet, Pierre, Tiberi, Marco, Domke, Ingrid, Debord, Jean, Sauvage, Francois-Ludovic, Saint-Marcoux, Franck, Therapeutic Drug Monitoring, 2007

Association analysis between m-TOR, p70S6k and Raptor polymorphisms and sirolimus adverse events in renal transplant patients, Marquet, P., Rostaing, L., Rousseau, A., Picard, N., Kamar, N., Woillard, J., Fundamental & Clinical Pharmacology, 2011

Darunavir unbound concentrations in plasma, not total concentration is the relevant concentration to predict darunavir efficacy in subject of different body mass index, Gandia, P., Delobel, P., Chatelut, E., Marquet, P., Debord, J., Seraissol, P., Toutain, P. L., Concordet, D., Woillard, J. B., Metsu, D., Fundamental & Clinical Pharmacology, 2018

Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: Pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients, Marquet, P., Jacqz-Aigrain, E., Saivin, S., Debruyne, D., Hary, L., Compagnon, P., Hoizey, G., Turcant, A., Loichot, C., Venisse, N., Le Meur, Y., Rousseau, A., Premaud, A., Pharmacological Research, 2010, 10.1016/j.phrs.2009.09.006

Mycophenolate exposure variability in the long term and influence of cyclosporine dose reduction in stable renal transplant recipients., Rousseau, Annick, Debruyne, Daniele, Paintaud, Gilles, Venisse, Nicolas, Hoizey, Guillaume, Saint-Marcoux, Franck, Etienne, Isabelle, Marquet, Pierre, American Journal of Transplantation, 2007

Population pharmacokinetic of gentamicin in hemodialysis patients: modeling, simulations and recommendations, Marquet, P., Woillard, J. B., Saint-Marcoux, F., Monchaud, C., Allot, V., Franck, B., Fundamental & Clinical Pharmacology, 2018

ASSOCIATION BETWEEN POLYMORPHISMS IN TARGET, METABOLISM OR TRANSPORT PROTEINS OF MYCOPHENOLATE SODIUM AND BPAR OR ADVERSE EVENTS IN RENAL TRANSPLANT PATIENTS, DOMINOS Study Grp, Marquet, Pierre, Touchard, Guy, Thierry, Antoine, Picard, Nicolas, Woillard, Jean-Baptiste, Transplant International, 2012

Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf (R) and once daily Advagraf (R), Rousseau, Annick, Rostaing, Lionel, Marquet, Pierre, Kamar, Nassim, de Winter, Brenda C. M., Woillard, Jean-Baptiste, British Journal of Clinical Pharmacology, 2011, 10.1111/j.1365-2125.2010.03837.x

Identification of acepromazine in hair: An illustration of the difficulties encountered in investigating drug-facilitated crimes, Lachatre, Gerard, Marquet, Pierre, Saint-Marcoux, Franck, Pauthier, Helene, Sauvage, Francois-Ludovic, Gaulier, Jean-Michel, Journal of Forensic Sciences, 2008, 10.1111/j.1556-4029.2008.00706.x

A double-absorption pharmacokinetic model for mycophenolate in de novo renal transplant patients, Marquet, P, Toupance, O, Le Meur, Y, Hoizey, G, Rousseau, A, Debord, J, Premaud, A, Therapeutic Drug Monitoring, 2003

HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents, Loustaud-Ratti, Veronique, Essig, Marie, Sautereau, Denis, Alain, Sophie, Marquet, Pierre, Mesturoux, Laura, Abraham, Julie, Debette-Gratien, Marilyne, Tabouret, Tessa, Jacques, Jeremie, Jaccard, Arnaud, Carrier, Paul, Liver International, 2015, 10.1111/liv.12897

Impact of NR1I2 (PXR) polymorphisms on tacrolimus pharmacokinetics in renal transplant patients, Le Meur, Yannick, Marquet, Pierre, Villemain, Florence, Toupance, Olivier, Hoizey, Guillaume, Rerolle, Jean-Philippe, Picard, Nicolas, Rousseau, Annick, Benkali, Khaled, American Journal of Transplantation, 2008

Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome, Harambat, Jerome, Decramer, Stephane, Marquet, Pierre, Bouchet, Stephane, Gandia, Peggy, Brochard, Karine, Morin, Denis, Godron, Astrid, Bandin, Flavio, Ichay, Lydia, Llanas, Brigitte, Saint-Marcoux, Frank, Guigonis, Vincent, Dallocchio, Aymeric, Tellier, Stephanie, Clinical Journal of the American Society of Nephrology, 2016, 10.2215/CJN.00320116

Steroid-Free Regimen and Optimization of Mycophenolic Acid (MPA) Exposure in Liver Graft Recipients: Final Results of the Celleste Study, Kamar, N., Tagieva, N., Dur, C., Sebagh, M., Marquet, P., Vanlemmens, C., Hardwigsen, J., Dharancy, S., Pageaux, G. P., Duvoux, C., Altieri, M., Calmus, Y., Neau-Cransac, M., Leroy, V., Radenne, S., Gugenheim, J., Durand, F., Saliba, F., American Journal of Transplantation, 2012

Towards a Generic Tool for Prediction of Meropenem Systemic and Infection-Site Exposure: A Physiologically Based Pharmacokinetic Model for Adult Patients with Pneumonia, , Drugs in R&D, 2019, 10.1007/s40268-019-0268-x

Analytical multi-site evaluation of the architect cyclosporine assay, Wonigeit, Kurt, Aimo, Giuseppe, Marquet, Pierre, Wallemacq, Pierre, Young, Julianna, Schmidt, Ed, Rosiere, Thomas K., Berg, Keith G., Maine, Greorv T., American Journal of Transplantation, 2008

Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients, Picard, Nicolas, Marquet, Pierre, Ali, Amany Mohamad, Thabet, Romany Helmy, Woillard, Jean-Baptiste, El Desoky, Ehab S., Hareedy, Mohammad Salem, Pharmacogenomics, 2015, 10.2217/PGS.15.62

[Pharmacogenetics and immunosuppressor drugs: impact and clinical interest in transplantation]., Picard, N, Djebli, N, Marquet, P, Annales pharmaceutiques francaises, 2007, 10.1016/S0003-4509(07)74197-4

A screening procedure for the determination of 13 oral anticoagulants and rodenticides, Lachatre, C, Merle, L, Debord, J, Marquet, P, Dreyfuss, MF, Lotfi, H, Journal of Analytical Toxicology, 1996

Proceedings of the 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Marquet, Pierre, Therapeutic Drug Monitoring, 2008

Contribution of CYP 3A4 and CYP 2D6 in loratadine metabolism in vitro, Marquet, P., Boughattas, N. A., Sauvage, F. L., Picard, N., Dridi, D., Fundamental & Clinical Pharmacology, 2007

Evidence for Hematocrit Influence on Tacrolimus Apparent Clearance and Application for TDM in Renal Transplant Recipients, Marquet, P., Rousseau, A., Le Meur, Y., Turcant, A., Villemain, F., Toupance, O., Hoizey, G., Rerolle, J. P., Picard, N., Premaud, A., Benkali, K., Therapeutic Drug Monitoring, 2009

Ultrafast Measurement of Metformin in the Clinical Setting Using Probe Electrospray Ionization Mass Spectrometry., Saint-Marcoux F, Dulaurent S, Lamoureux F, Marquet P, Griffeuille P, El Balkhi S, Bodeau S, Journal of analytical toxicology, 2023, 10.1093/jat/bkac034

Applications of liquid chromatography mass spectrometry in analytical toxicology: A review, Lachatre, G, Penicaut, B, Lotfi, H, Verneuil, B, Marquet, P, Hoja, H, Journal of Analytical Toxicology, 1997

Prognostic value of ribavirin AUC0-12 h after the first dose in genotype 1 chronic hepatitis C patients given ribavirin and peginterferon alpha-2a (40 kDa), Marquet, P., Vidal, E., Cales, P., Lefevre, A., Fouchard-Hubert, I., Sauvage, F. L., Alain, S., Loustaud-Ratti, V., Rousseau, A., Fundamental & Clinical Pharmacology, 2007

Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes., Di Meo F, Marquet P, Barin-Le Guellec C, Chantemargue B, Martin M, Faucher Q, Tóth Á, Janaszkiewicz A, Scientific reports, 2022, 10.1038/s41598-022-10755-2

LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays., Marquet, Pierre, Methods in molecular biology (Clifton, N.J.), 2012, 10.1007/978-1-61779-934-1_2

Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5, Marquet, P, Premaud, A, Cresteil, T, Picard, N, Therapeutic Drug Monitoring, 2004, 10.1097/00007691-200412000-00004

Exploring different DNA extraction and genotyping techniques in medium-scale pharmacogenetic research, Picard, N., Marquet, P., Abraham, J., Koitka, M., Fundamental & Clinical Pharmacology, 2011

Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study., , EBioMedicine, 2019, 10.1016/j.ebiom.2019.07.028

How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation, Marquet, Pierre, Essig, Marie, Bocquentin, Frederique, Friedl, Jennifer, Monchaud, Caroline, Woillard, Jean-Baptiste, Saint-Marcoux, Franck, Pharmacological Research, 2015, 10.1016/j.phrs.2015.08.020

A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation., Woillard JB, Premaud A, Guellec CB, Ehrmann S, Carrier P, Loustaud-Ratti V, Åsberg A, Gandonnière CS, Marquet P, Destere A, Clinical pharmacokinetics, 2022, 10.1007/s40262-022-01138-x

A specific analytical method for the analysis of 24 antidepressants using gas chromatography-mass spectrometry (GC/MS), Lachatre, G, Marquet, P, Gaulier, JM, Ragot, S, Lacassie, E, Acta Clinica Belgica, 1999

Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients., Woillard JB, Marquet P, Monchaud C, Premaud A, Destere A, Therapeutic drug monitoring, 2023, 10.1097/ftd.0000000000001035

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation., Naesens M, Noël LH, Sprangers B, Kuypers D, Thorrez L, Thaunat O, Koenig A, Saison C, Heylen L, Wevers M, de Loor H, Lerut E, Gazut S, Callemeyn J, Yazdani S, Kidney international, 2018, 10.1016/j.kint.2018.08.027

New tools for cyclosporine dose optimization in thoracic transplant recipients, Marquet, P., Rousseau, A., Stern, M., Sebbag, L., Rolle, F., Reynaud-Gaubert, M., Redonnet, M., Pison, C., Knoop, C., Kessler, R., Guillemain, R., Estenne, M., Epailly, E., Premaud, A., Fruit, D., Fundamental & Clinical Pharmacology, 2011

Therapeutic drug monitoring of antidepressants in human serum using a fully automated turbulent-flow - Liquid hromatography - Tandem mass spectrometry technique, Marquet, P, Lachatre, G, Gaulier, JM, Sauvage, FL, Therapeutic Drug Monitoring, 2005

FP7 BIOMARGIN: SMALL SETS OF URINARY CELL mRNAs LEADING TO A PARTITION TREE ON KIDNEY ALLOGRAFT LESIONS, Anglicheau, D., Marquet, P., Essig, M., Gwinner, W., Naesens, M., Gazut, S., Morin, L., Benon, A., Tinel, C., Transplant International, 2018

Buprenorphine withdrawal syndrome in a newborn, Lachatre, G, Merle, L, Lavignasse, P, Chevrel, J, Marquet, P, Clinical Pharmacology & Therapeutics, 1997, 10.1016/S0009-9236(97)90053-9

Buprenorphine and norbuprenorphine determination in urine and serum by liquid chromatography mass spectrometry with electrospray-type ionization., Lachatre, G, Dreyfuss, MF, Dupuy, JL, Verneuil, B, Lotfi, H, Hoja, H, Marquet, P, Analusis, 1996

Interaction of everolimus and sirolimus with the hepatic and intestinal Organic Anion Transporting Polypeptides (OATPs), Marquet, P., Giacomini, K. M., Yee, S. W., Lamoureux, F., Levoir, L., Picard, N., Fundamental & Clinical Pharmacology, 2010

Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First Year Post-Liver Transplantation., , Transplantation, 2020, 10.1097/tp.0000000000003384

Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry, Dupuy, JL, Cardot, P, Gaulier, JM, Ragot, S, Marquet, P, Lachatre, F, Journal of Chromatography B, 2000, 10.1016/S0378-4347(99)00529-0

Metabolic alterations of uterine grafts after extended cold ischemic storage: experimental study in ewes., , Molecular human reproduction, 2019, 10.1093/molehr/gaz041

QuEChERS sample preparation prior to LC-MS/MS determination of opiates, amphetamines, and cocaine metabolites in whole blood, Saint-Marcoux, Franck, Marquet, Pierre, Gaulier, Jean-Michel, Poncelet, Lauranne, El Balkhi, Souleiman, Dulaurent, Sylvain, Analytical and Bioanalytical Chemistry, 2016, 10.1007/s00216-015-9248-3

Buprenorphine maintenance treatment in primary care - An overview of the French experience and insight into the prison setting, Marquet, P, Kintz, P, Vignau, J, Deveaux, M, Buprenorphine Therapy of Opiate Addiction, 2002

A multivariate genetic analysis of glucuronidation and biliary excretion gene polymorphisms associated with mycophenolate acid related diarrhea in renal transplant patients, Marquet, P., Le Meur, Y., Drouet, M., Rerolle, J. P., Rousseau, A., Picard, N., Woillard, J. B., Fundamental & Clinical Pharmacology, 2009

Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study, Pourrat, O, Tilhet-Coart, S, Moulsma, M, Nouveau, J, Goulle, JP, Kaddour, A, Vincent, F, Martin-Dupont, S, Marquet, P, Gaulier, JM, Ludes, B, Kintz, P, Mura, P, Forensic Science International, 2003, 10.1016/S0379-0738(03)00052-5

VALIDATION OF A FRENCH SELF-ADMINISTRATED QUESTIONNAIRE ABOUT QUALITY OF LIFE IN RENAL TRANSPLANT RECIPIENTS TRANSPLANTED FOR LESS THAN 12 MONTHS, Marquet, Pierre, Jouve, Elisabeth, Rousseau, Annick, Gentile, Stephanie, Laroche, Marie-Laure, Beauger, Davy, Fruit, Dorothee, Transplant International, 2012

Feasibility of Ribavirin Therapeutic Drug Monitoring in Hepatitis C, Marquet, Pierre, Babany, Gerard, Jourdil, Jean-Francois, Gagnieu, Marie-Claude, Stanke-Labesque, Francoise, Sauvage, Francois-Ludovic, Therapeutic Drug Monitoring, 2009

Ribavirin in chronic hepatitis C: past and future, Denis, Francois, Alain, Sophie, Marquet, Pierre, Rousseau, Annick, Loustaud-Ratti, Veronique, Expert Review of Anti-Infective Therapy, 2009, 10.1586/eri.09.5

LC-MS/MS screen for xenobiotics and metabolites., Marquet, Pierre, Sauvage, Francois-Ludovic, Methods in molecular biology (Clifton, N.J.), 2012, 10.1007/978-1-61779-934-1_11

Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients, Picard, Nicolas, Marquet, Pierre, Rostaing, Lionel, Rousseau, Annick, Kamar, Nassim, Woillard, Jean-Baptiste, Pharmacogenetics and Genomics, 2012, 10.1097/FPC.0b013e328357359d

Separative techniques for determination of buprenorphihe, Marquet, P, Kintz, P, Cirimele, V, Buprenorphine Therapy of Opiate Addiction, 2002

Perfusate Metabolomics Content and Expression of Tubular Transporters During Human Kidney Graft Preservation by Hypothermic Machine Perfusion., Barin-Le Guellec C, Marquet P, Bruyère F, Brichart N, Venhard JC, Arnion H, Nadal-Desbarats L, Miquelestorena-Standley E, Forestier L, Sauvage FL, Alarcan H, Faucher Q, Transplantation, 2022, 10.1097/tp.0000000000004129

Tools for routine dose adjustment of mycophenolate mofetil based on MPA AUC bayesian estimation: The experience with a new enzymatic assay, Marquet, Pierre, Tiberi, Marco, Domke, Ingrid, Debord, Jean, Sauvage, Francois-Ludovic, Saint-Marcoux, Franck, Transplant International, 2007

Multisite Analytical Evaluation of the Abbott ARCHITECT Cyclosporine Assay, Schmid, Rainer W., Wermuth, Bendicht, Kretschmer, Robert, Wonigeit, Kurt, Young, Julianna, Mengozzi, Giulio, Aimo, Giuseppe, Marquet, Pierre, Rosiere, Thomas, Berg, Keith, Maine, Gregory T., Wallemacq, Pierre, Therapeutic Drug Monitoring, 2010, 10.1097/FTD.0b013e3181d46386

The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study., , Transplant international : official journal of the European Society for Organ Transplantation, 2020, 10.1111/tri.13624

Ribavirin pharmacokinetic study will lead to individual dose adjustment in chronic hepatitis C patients, Vidal, E, Liozon, E, Lefebvre, A, Lunel, F, Denis, F, Marquet, P, Lemonnier, L, Alain, S, Loustaud-Ratti, V, Hepatology, 2004

Influence of cyclosporine dose on the main mycophenolate mofetil pharmacokinetic parameters, Stankevicius, Edgaras, Kadusevicius, Edmundas, Marquet, Pierre, Saint-Marcoux, Franck, Noreikaite, Aurelija, Acta Physiologica, 2016

Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry, Marquet, Pierre, Lachatre, Gerard, Deporte, Didier, Duretz, Benedicte, Saint-Marcoux, Franck, Sauvage, Francois-Ludovic, Clinical Chemistry, 2006, 10.1373/clinchem.2006.067116

Contribution of the Different UDP-Glucuronosyltransferase (UGT) Isoforms to Buprenorphine and Norbuprenorphine Metabolism and Relationship with the Main UGT Polymorphisms in a Bank of Human Liver Microsomes, Marquet, Pierre, Gaulier, Jean-Michel, Sauvage, Francois-Ludovic, Picard, Nicolas, Rouguieg, Koukeb, Drug Metabolism and Disposition, 2010, 10.1124/dmd.109.029546

Killing two birds with one stone: a population pharmacokinetic model for two tacrolimus formulations, Marquet, P., Rostaing, L., Rousseau, A., Kamar, N., de Winter, B. C. M., Woillard, J. B., Therapeutic Drug Monitoring, 2011

Pharmacokinetics and Therapeutic Drug Monitoring of anticancer agents, Rousseau, Annick, Marquet, Pierre, Bulletin Du Cancer, 2008, 10.1684/bdc.2008.0725

CYCLOSPORINE A, BUT NOT TACROLIMUS, INHIBITS THE SERUM RESPONSIVE PATHWAY OF PROXIMAL TUBULAR CELLS THROUGH COFILIN INHIBITION AND REORGANIZATION OF F-ACTIN BRANCHED MESHWORK, Essig, M., Marquet, P., Pinault, E., Sauvage, F. L., Gonzalez, J., Burat, B., Transplant International, 2017

Sirolimus oral clearance is significantly higher in CYP3A5*1 vs CYP3A5*3 de novo renal transplant recipients with no associated calcineurin inhibitor., Le Meur, Y, Rousseau, A, Hoizey, G, Toupance, O, Djebli, N, Marquet, P, American Journal of Transplantation, 2005

Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation., , European journal of clinical pharmacology, 2019, 10.1007/s00228-019-02716-y

Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: Comparison between cystic fibrosis and other conditions, Estenne, M, Marquet, P, Rousseau, A, Kovarik, JM, De Backer, M, Thiry, P, Vervier, I, Knoop, C, Transplantation, 2003, 10.1097/01.TP.0000076473.71399.26

Maximum A posteriori Bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods, Marquet, P, Toiipance, O, Hoizey, G, Rousseau, A, Szelag, JC, Debord, J, Le Meur, Y, Premaud, A, Therapeutic Drug Monitoring, 2005

Fatal intoxications with chloral hydrate, Lachatre, G, Marquet, P, Haglund, P, Courtiade, B, Lacassie, E, Merle, G, Gaulier, JM, Journal of Forensic Sciences, 2001

A Machine Learning Approach to Predict Interdose Vancomycin Exposure., Woillard JB, Wicha SG, Marquet P, Labriffe M, Sidorov E, Uster DW, Bououda M, Pharmaceutical research, 2022, 10.1007/s11095-022-03252-8

Uterine Factor Infertility, a Systematic Review., Gauthier T, Dion L, Lavoué V, Aubard Y, Piver P, Marquet P, Margueritte F, Sallée C, Journal of clinical medicine, 2022, 10.3390/jcm11164907

2019 American Transplant Congress Abstracts., , American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, 10.1111/ajt.15405

Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms, Saint-Marcoux, Franck, Marquet, Pierre, Essig, Marie, Alain, Sophie, Tafzi, Naima, Picard, Nicolas, Sauvage, Francois-Ludovic, Billat, Pierre-Andre, Analytical and Bioanalytical Chemistry, 2015, 10.1007/s00216-015-8554-0

Population analysis and covariates influencing the pharmacokinetics of mycophenolic acid in renal transplant recipients, Rousseau, A, Marquet, P, Hoizey, G, Toupance, O, Szelag, JC, Le Meur, YPA, Therapeutic Drug Monitoring, 2005

CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients, Marquet, Pierre, Rerolle, Jean Philippe, Toupance, Olivier, Hoizey, Guillaume, Szelag, Jean-Christophe, Djebli, Nassim, Le Meur, Yannick, Clinical Pharmacology & Therapeutics, 2006, 10.1016/j.clpt.2006.03.012

A non-fatal case of intoxication with foxglove, documented by means of liquid chromatography-electrospray-mass spectrometry, Lachatre, G, Gaulier, JM, Martin-Dupont, S, Marquet, P, Lacassie, E, Journal of Forensic Sciences, 2000

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study, French CMV Resistance Survey Study, Alain, Sophie, Turlure, Pascal, Lebranchu, Yvon, Pillet, Sylvie, Germi, Raphaelle, Cotin, Sebastien, Rerolle, Jean-Philippe, Essig, Marie, Saint Marcoux, Franck, Rostaing, Lionel, Mengelle, Catherine, Merville, Pierre, Garrigue, Isabelle, Mazeron, Marie-Christine, Garnier-Geoffroy, Francoise, Hantz, Sebastien, Journal of Antimicrobial Chemotherapy, 2010, 10.1093/jac/dkq368

Mycophenolic Acid 12-Hour Area Under the Curve in De Novo Liver Transplant Patients Given Mycophenolate Mofetil at Fixed Versus Concentration-Controlled Doses, Rostaing, Lionel, Saint-Marcoux, Franck, Suc, Bertrand, Alric, Laurent, Peron, Jean Marie, Canivet, Cindy, Guitard, Joelle, Esposito, Laure, Lavayssi, Laurence, Muscari, Fabrice, Gandia, Peggy, Marquet, Pierre, Kamar, Nassim, Therapeutic Drug Monitoring, 2009

Identificaion of a phase I metabolite of mycophenolic aced produced by CYP 450 3A4/5, Le Meur, Y, Marquet, P, Cresteil, T, Picard, N, Therapeutic Drug Monitoring, 2003

CYP3A5 genotype influences differently the hepatic clearance of tacrolimus, sirolimus and everolimus, Marquet, Pierre, Sauvage, Francois-Ludovic, Djebli, Nassim, Picard, Nicolas, Therapeutic Drug Monitoring, 2007

Predicting liver glucuronidation activities from heterologously expressed UDP-glucuronosyltransferases: application to morphine, Marquet, P., Gagez, A. L., Sauvage, F. L., Rouguieg-Malki, K., Chettouh, Z., Picard, N., Therapeutic Drug Monitoring, 2011

Performance of the New Mycophenolate Assay Based on IMPDH Enzymatic Activity for Pharmacokinetic Investigations and Setup of Bayesian Estimators in Different Populations of Allograft Recipients, Debord, Jean, Domke, Ingrid, Tiberi, Marco, Lebranchu, Yvon, Knoop, Christiane, Jaqz-Aigrain, Evelyne, Sauvage, Francois-Ludovic, Premaud, Aurelie, Saint-Marcoux, Franck, Marquet, Pierre, Therapeutic Drug Monitoring, 2009

Case study of neonates born to mothers undergoing buprenorphine maintenance treatment, Kintz, P, Lachatre, G, Gaulier, JM, Lavignasse, P, Marquet, P, Buprenorphine Therapy of Opiate Addiction, 2002

Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients, Marquet, P., Saint-Marcoux, F., Monchaud, C., Debord, J., Woillard, J. B., Clinical Pharmacokinetics, 2017, 10.1007/s40262-017-0533-5

In vitro study of mycophenolic acid glucuronidation, Marquet, P, Picard, N, Drug Metabolism and Disposition, 2004, 10.1124/dmd.104.001982

Analytical multi-site evaluation of the Abbott ARCHITECT Cyclosporine assay, Wonigeit, K., Marquet, P., Aimo, G., Schmid, R., Young, J., Schmidt, E., Berg, K., Ait-Youcef, H., Wallemacq, P., Maine, G. T., Clinical Chemistry, 2008

Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation, Rousseau, Annick, Marquet, Pierre, Kamar, Nassim, Urien, Saik, Saint-Marcoux, Franck, Woillard, Jean-Baptiste, Premaud, Aurelie, Rostaing, Lionel, Benkali, Khaled, Clinical Pharmacokinetics, 2010

Tungsten determination in biological fluids, hair and nails by plasma emission spectrometry in a case of severe acute intoxication in man, Lachatre, G, Nedelec, G, Debord, J, Turcant, A, Lotfi, H, Francois, B, Marquet, P, Journal of Forensic Sciences, 1997

Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma, Marquet, P, Lachatre, G, Debord, J, Delephine, G, Delephine, N, Sabot, C, Rousseau, A, Clinical Pharmacokinetics, 2002, 10.2165/00003088-200241130-00006

New Tools for Tacrolimus (Tac) Dose Optimization In Lung Transplant Recipients during the First Post-Transplant Year: Preliminary Results of STIMMUGREP Study, Marquet, P., Rousseau, A., Guilllemain, R., Dromer, C., Kessler, R., Pison, C., Reynaud-Gaubert, M., Estenne, M., Monchaud, C., Journal of Heart and Lung Transplantation, 2009

Statistics of MMF dose adjustment on ISBA, a free website for dose adjustment of immunosuppressive drugs, Marquet, P., Sequier, G., Canal, M., Tribut, O., Hoizey, G., Debord, J., Saint-Marcoux, F., Therapeutic Drug Monitoring, 2007

Antibody-mediated rejection with and without donor-specific anti-human leucocyte antigen antibodies: performance of the peripheral blood 8-gene expression assay., , Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 10.1093/ndt/gfaa096

In the post-APOMYGRE era: ISBA, a free website for Bayesian dose adjustment of immunosuppressive drugs, Grp Suivi Therapeut Pharmacol SEPT, Marquet, P., Sequier, G., Canal, M., Tribut, O., Hoizey, G., Debord, J., Saint-Marcoux, F., Fundamental & Clinical Pharmacology, 2007

Optimizing ribavirin dosage: A new challenge to improve treatment efficacy in genotype 1 hepatitis C patients, French Ribavirin Grp OPTIRIB, Trepo, C., Babany, G., Maynard, M., Gagnieu, M. -C., Marquet, P., Stanke-Labesque, F., Loustaud-Ratti, V., Gastroenterologie Clinique Et Biologique, 2009, 10.1016/j.gcb.2009.04.009

Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus, Wallemacq, P, Barnes, G, Schmid, R, Fillee, C, Brunet, M, Streit, F, Mosso, R, Oellerich, M, Moscato, D, Marquet, P, Luthe, H, Gaulier, JM, Engelmayer, J, Moreton, M, Holt, D, Johnston, F, Wilson, D, Clinical Biochemistry, 2006, 10.1016/j.clinbiochem.2006.01.017

Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies., , Journal of the American Society of Nephrology : JASN, 2020, 10.1681/asn.2020030306

Lessons from Routine Dose Adjustment of Tacrolimus Based on Global Exposure in Renal Transplant Patients, Marquet, P., Woillard, J. B., Jurado, C., Saint-Marcoux, F., American Journal of Transplantation, 2012

T-Cell Activation and Proliferation Measurements as Pharmacodynamic Biomarkers of Mycophenolic Acid Exposure., Kamar, Nassim, Rostaing, Lionel, Marquet, Pierre, Rousseau, Annick, Gandia, Peggy, Boehler, Torsten, Premaud, Aurelie, Canivet, Cindy, Johnson, Gyasi, American Journal of Transplantation, 2009

The Role of Organic Anion-Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics, Marquet, P., Giacomini, K. M., Le Meur, Y., Lebranchu, Y., Woillard, J-B, Yee, S. W., Picard, N., Clinical Pharmacology & Therapeutics, 2010, 10.1038/clpt.2009.205

Co-Medication with Cyclosporine and the UDP-Glucuronosyltransferase (UGT) 1A8*2 Allele Are Associated with a Decreased Risk of Mycophenolate Mofetil Related Diarrhea in Renal Transplant Patients., Le Meur, Yann, Marquet, Pierre, Drouet, Mireille, Rousseau, Annick, Picard, Nicolas, Woillard, Jean-Baptiste, Rerolle, Jean-Philippe, American Journal of Transplantation, 2009

Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients, Lachatre, G, Merle, L, Carpentier, N, Debord, J, Marquet, P, Sabot, C, European Journal of Clinical Pharmacology, 1998, 10.1007/s002280050441

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches, Rousseau, A., Marquet, P., Urien, S., Oellerich, M., Armstrong, V. W., Toenshoff, B., Weber, L. T., Premaud, A., Pharmacological Research, 2011, 10.1016/j.phrs.2010.10.017

Native Urinary Peptides Identified as Biomarkers of Graft Lesions in Renal Transplant Recipients., Gastinel, L. N., Delahousse, M., Cassuto-Viguier, E., Bayle, F., Taguieva, N., Le Meur, Y., Gagez, A. -L., Marquet, P., American Journal of Transplantation, 2011

A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity, Guellec, C. B. L., Marquet, P., Choquet, S., Abraham, J., Girault, S., Turlure, P., Saint-Marcoux, F., Benz-de-Bretagne, I., Debord, J., Woillard, J. B., Therapeutic Drug Monitoring, 2017, 10.1097/ftd.0000000000000381

Adherence profiles in kidney transplant patients: Causes and consequences., , Patient education and counseling, 2019, 10.1016/j.pec.2019.08.002

Functions of the Therapeutic Drug Monitoring (TDM) group of the French Society of Pharmacology, Marquet, P, Therapie, 2001

Strychnine poisoning in rural areas, Gay, R, Lachatre, G, Billy, V, Marquet, P, Cailloce, D, Francois, B, Presse Medicale, 1996

In vitro comparison of the influence of the cyp 3A5*3 single nucleotide polymorphism on the hepatic clearance of three immunosuppressive drugs: everolimus, sirolimus and tacrolimus, Marquet, P., Sauvage, F. L., Comte, J. H., Djebli, N., Picard, N., Fundamental & Clinical Pharmacology, 2007

Development of Bayesian estimators for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome, Marquet, P., Berard, E., Broux, F., Harambat, J., Bouissou, F., Palcoux, J., Guigonis, V., Ranchin, B., Saint-Marcoux, F., Fundamental & Clinical Pharmacology, 2009

Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study, Marquet, Pierre, Samuel, Didier, Sebagh, Mylene, Sinnasse-Raymond, Gilles, Taguieva, Naila, Duvoux, Christophe, Pageaux, Georges-Philippe, Salame, Ephrem, Calmus, Yvon, Neau-Cransac, Martine, Leroy, Vincent, Radenne, Sylvie, Durand, Francois, Gugenheim, Jean, Rostaing, Lionel, Saliba, Faouzi, Transplantation, 2016, 10.1097/TP.0000000000001228

Tacrolimus (Tac) Pharmacokinetics (PK) in Cystic Fibrosis (CF) and Non-CF Lung Transplant Recipients: Preliminary Results of the STIMMUGREP Trial., Marquet, Pierre, Rousseau, Annick, Guillemain, Romain, Dromer, Claire, Kessler, Romain, Stern, Marc, Pison, Christophe, Reynaud-Gaubert, Martine, Monchaud, Caroline, Estenne, Marc, American Journal of Transplantation, 2009

Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics, Aranzazu Sancho-Lopez, Joaquin Sáez-Peñataro, Emilie Jouanjus, Pierre Marquet, European Journal of Clinical Pharmacology, 2024, 10.1007/s00228-024-03657-x

Analytical findings in a suicide involving sodium azide, Lachatre, G, Dumont, D, Debord, E, Dreyfuss, MF, Lotfi, H, Clement, S, Marquet, P, Journal of Analytical Toxicology, 1996

Integrative Omics Analysis Unravels Microvascular Inflammation-Related Pathways in Kidney Allograft Biopsies., Anglicheau D, Naesens M, Marquet P, Gwinner W, Rabant M, Aouni L, Morin L, Sauvaget V, Van Loon E, Callemeyn J, Lamarthée B, Tinel C, Frontiers in immunology, 2021, 10.3389/fimmu.2021.738795

Influence of ABCB1 donor genotype on graft loss in a retrospective cohort of renal transplant patients receiving CyclosporineA, Marquet, Pierre, Drouet, Mireille, Rousseau, Annick, Rerolle, Jean-Philippe, Picard, Nicolas, Woillard, Jean-Baptiste, Le Meur, Yannick, American Journal of Transplantation, 2008

Bridging the Worlds of Pharmacometrics and Machine Learning, Mihaela van der Schaar, Pierre Marquet, Richard W. Peck, Jean-Baptiste Woillard, Kamilė Stankevičiūtė, Clinical Pharmacokinetics, 2023, 10.1007/s40262-023-01310-x

Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale., Di Meo F, Marquet P, Barin-Le Guellec C, Védrenne N, Arnion H, Tóth Á, Faucher Q, Janaszkiewicz A, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, 10.1016/j.biopha.2023.114342

Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants, Marquet, P, Paintaud, G, Lachatre, G, Buchler, M, Rousseau, A, Le Meur, Y, Debord, J, Leger, F, Clinical Pharmacokinetics, 2002, 10.2165/00003088-200241010-00006

Mycophenolic Acid Area Under the Curve Correlates With Disease Activity in Lupus Patients Treated With Mycophenolate Mofetil, Amoura, Zahir, Piette, Jean-Charles, Funck-Brentano, Christian, Hulot, Jean-Sebastien, Costedoat-Chalumeau, Nathalie, Haroche, Julien, Marquet, Pierre, Arnaud, Laurent, Zahr, Noel, Arthritis and Rheumatism, 2010, 10.1002/art.27495

Determination of three beta-blockers in biofluids and solid tissues by liquid chromatography-electrospray-mass spectrometry, Lachatre, U, Marquet, P, Pelissier-Alicot, AL, Gaulier, JM, Dupuis, C, Journal of Analytical Toxicology, 2004

Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients, Rousseau, Annick, Marquet, Pierre, Le Meur, Yannick, Villemain, Florence, Turcant, Alain, Hoizey, Guillaume, Toupance, Olivier, Rerolle, Jean-Philippe, Picard, Nicolas, Premaud, Aurelie, Benkali, Khaled, Clinical Pharmacokinetics, 2009

Bayesian estimation of mycophenolate mofetil (MMF) in lung transplantation using a population pharmacokinetic model developed in renal and lung transplant recipients, Rousseau, A., Marquet, P., Estenne, M., Knoop, C., Guillemain, R., Stern, M., Dromer, C., Reynaud-Gaubert, M., Kessler, R., Pison, C., Premaud, A., De Winter, B., Monchaud, C., Fundamental & Clinical Pharmacology, 2011

Modelling ciclosporin double-peak absorption profiles in,the early post-transplantation period, Marquet, P, Rousseau, A, Clinical Pharmacokinetics, 2004, 10.2165/00003088-200443140-00007

EXPRESSION OF HLA CLASS I AND II MOLECULES ON THE DIFFERENT COMPOUNDS OF THE UTERUS, Gauthier, Tristan, Marquet, Pierre, Aubard, Yves, Piver, Pascal, Ribes, Romain, Essig, Marie, Guillaideau, Angerlique, Filloux, Matthieu, Pacha, Adam Fodil, Drouet, Mireille, Tissue Antigens, 2015

Mycophenolate pharmacokinetics in cystic fibrosis and non-cystic fibrosis lung transplant recipients: preliminary results of the STIMMUGREP trial, Marquet, P., Rousseau, A., Romain, G., Dromer, C., Marc, E., Stern, M., Reynaud-Gaubert, M., Kessler, R., Pison, C., Monchaud, C., Fundamental & Clinical Pharmacology, 2009

General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism, Marquet, Pierre, Boughaftas, Naceur A., Sauvage, Francois-Ludovic, Dridi, Dorra, Picard, Nicolas, Journal of Separation Science, 2009, 10.1002/jssc.200900099

AADAPT-Analysis of Advagraf Dose Adaptation Post Transplantation, Marquet, P., Thervet, E., Charpentier, B., Lebranchu, Y., Rostaing, L., Cassuto, E., Albano, L., American Journal of Transplantation, 2014

Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry, Lachatre, Gerard, Gaulier, Jean-Michel, Marquet, Pierre, Moesch, Christian, Dulaurent, Sylvain, Analytical and Bioanalytical Chemistry, 2010, 10.1007/s00216-009-3443-z

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study, Silvente-Poirot, S., Poirot, M., Roche, H., Samadi, M., Marquet, P., Chatelut, E., Arellano, C., Voisin, M., Zerbinati, C., Filleron, T., Iuliano, L., Dalenc, F., Journal of Steroid Biochemistry and Molecular Biology, 2017, 10.1016/j.jsbmb.2016.06.010

Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism, Marquet, P, Le Meur, Y, Premaud, A, Ratanasavanh, D, Picard, N, Drug Metabolism and Disposition, 2005, 10.1124/dmd.104.001651

Current role of LC-MS in therapeutic drug monitoring, Marquet, Pierre, Sauvagge, Francois-Ludovic, Saint-Marcoux, Franck, Analytical and Bioanalytical Chemistry, 2007, 10.1007/s00216-007-1320-1

In vitro and in vivo study of the antithyroid side effects of trimeprazine, Lachatre, G, Raby, C, Dumeirain, F, Marquet, P, Rousseau, A, Sauvage, MF, Toxicology and Applied Pharmacology, 1999, 10.1006/taap.1999.8699

Pharmacokinetic Tools for, and Clinical Findings in Favour of, the Therapeutic Drug Monitoring of Mycophenolate Mofetil in Children with Idiopathic Nephrotic Syndrome, Marquet, P., Berard, E., Broux, F., Harambat, J., Bouissou, F., Palcoux, J. B., Ranchin, B., Saint-Marcoux, F., Guigonis, V., Pediatric Nephrology, 2010

Tacrolimus Bayesian dose adjustment in pediatric renal transplant recipients., , Therapeutic drug monitoring, 2020, 10.1097/ftd.0000000000000828

A soldier who had seizures after drinking quarter of a litre of wine, Lachatre, G, Vignon, P, Francois, B, Marquet, P, Lancet, 1996, 10.1016/S0140-6736(96)05459-1

[Not Available]., Verstuyft, Celine, Tisseau, Anne, Pigeon, Martine, Perin-Dureau, Florent, Perche, Olivier, Morin-Surroca, Michele, Mourah, Samia, Hoog-Labouret, Natalie, Gueyffier, Francois, Goni, Sylvia, Froguel, Philippe, Divine, Marine, Diaz, Isabelle, Chatelut, Etienne, Cazeneuve, Beatrice, Auge, Pascale, Ameye, Veronique, les participants a la table ronde N°1 de Giens XXX :, Barlesi, Fabrice, Longeray, Pierre-Henry, Marquet, Pierre, Therapie, 2015, 10.2515/therapie/2014230

Phenotyping of Uracil and 5-Fluorouracil Metabolism Using LC-MS/MS for Prevention of Toxicity and Dose Adjustment of Fluoropyrimidines., , Therapeutic drug monitoring, 2020, 10.1097/ftd.0000000000000768

Analytical evaluation of the Abbott ARCHITECT cyclosporine assay in comparison to LC/MS/MS and Dade Dimension Xpand, Wonigeit, K., Marquet, P., Aimo, G., Schmid, R. W., Schmidt, E., Young, J., Berg, K., Ait-Youcef, H., Wallemacq, P., Maine, G. T., Clinical Biochemistry, 2008, 10.1016/j.clinbiochem.2008.08.032

Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation, Rousseau, Annick, Marquet, Pierre, Guillemain, Romain, Kessler, Romain, Stern, Marc, Pison, Christophe, Reynaud-Gaubert, Martine, Estenne, Marc, Knoop, Christiane, de Winter, Brenda C., Monchaud, Caroline, Clinical Pharmacokinetics, 2012

Sensitive and specific multiresidue methods for the determination of pesticides of various classes in clinical and forensic toxicology, Lachatre, G, Dreyfuss, MF, Gaulier, JM, Marquet, P, Lacassie, E, Forensic Science International, 2001, 10.1016/S0379-0738(01)00461-3

Therapeutic Drug Monitoring of Everolimus: A Consensus Report, Marquet, Pierre, Thompson, Carol, Morris, Raymond G., Wallemacq, Pierre, Langman, Loralie J., Oellerich, Michael, Picard, Nicolas, Seger, Christoph, Masuda, Satohiro, Millan Lopez, Olga, Wieland, Eberhard, De Simone, Paolo, Barten, Markus J., Budde, Klemens, Brunet, Merce, Kunicki, Pawel K., van Gelder, Teun, Billaud, Eliane M., Holt, David W., Hesselink, Dennis A., Shipkova, Maria, Therapeutic Drug Monitoring, 2016

Sirolimus population pharmacokinetic/pharmacogenetic analysis and Bayesian modelling in kidney transplant recipients, Marquet, Pierre, Le Meur, Yann, Toupance, Olivier, Rerolle, Jean-Philippe, Hoizey, Guillaume, Rousseau, Annick, Djebli, Nassim, Clinical Pharmacokinetics, 2006, 10.2165/00003088-200645110-00007

New Tools for Mycophenolate Mofetil (MMF) Dose Optimization in Lung Transplant Recipients during the First Year Post-Transplantation: The STIMMUGREP Trial, Marquet, P., Kessler, R., Estenne, M., Knoop, C., Guillemain, R., Stern, M., Reynaud-Gaubert, M., Pison, C., Monchaud, C., Journal of Heart and Lung Transplantation, 2011

Relationship between exposure to calcineurin inhibitors over the first year after kidney transplantation and infections: a cohort study, Monchaud, C., Marquet, P., Essig, M., Kamar, N., Merville, P., Bouchet, S., Lacroix, I., Coubret, A., Laroche, M. L., Woillard, J. B., Villeneuve, C., Trouche-Estival, B., Fundamental & Clinical Pharmacology, 2017

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology., , Therapeutic drug monitoring, 2021, 10.1097/ftd.0000000000000871

A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic Fibrosis., , Therapeutic drug monitoring, 2020, 10.1097/ftd.0000000000000855

Screening procedure for 21 amphetamine-related compounds in urine using solid-phase microextraction and gas chromatography mass spectrometry, Lachatre, G, Lacassie, E, Fauconnet, AL, Marquet, P, Battu, C, Journal of Chromatographic Science, 1998

Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation, Jean‐Baptiste Woillard, Philippe Ovetchkine, Pierre Marquet, Julie Autmizguine, Bénédicte Franck, Clinical Pharmacology & Therapeutics, 2022, 10.1002/cpt.2431

A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction., Woillard JB, Drici MD, Labriffe M, Marquet P, Destere A, Pharmaceutical research, 2023, 10.1007/s11095-023-03507-y

Higher exposure to mycophcnolic acid with sirohmus than with cyclosporine cotreatment, Paintaud, G, Marquet, P, Hary, L, Libert, F, le Guellec, C, Westeel, PF, Heng, AE, Le Meur, Y, Beneton, M, Lebranchu, Y, Buchler, M, Clinical Pharmacology & Therapeutics, 2005, 10.1016/j.clpt.2005.03.005

Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection, Naesens M, Koshy P, Gwinner W, Franken A, Eloudzeri M, Vusser KD, Smet FD, Debyser T, Becker JU, Anglicheau D, Antoranz A, Herck YV, Callemeyn J, Lamarthée B, 2022, 10.1101/2022.07.07.22276374

Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure - Reply, Marquet, Pierre, Rousseau, Annick, Alain, Sophie, Loustaud-Ratti, Veronique, Hepatology, 2008, 10.1002/hep.22454

Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm, Lachatre, G, Merle, L, Marquet, P, Charmes, JP, Debord, J, International Journal of Clinical Pharmacology and Therapeutics, 1997

Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?, Treves, R, Lachatre, G, Debord, J, Bonnet, C, Sabot, C, Marquet, P, Bertin, P, Carpentier, N, Journal of Rheumatology, 1998

Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters, Marquet, Pierre, Giacomini, Kathleen M., Yee, Sook Wah, Lamoureux, Fabien, Levoir, Laure, Picard, Nicolas, Xenobiotica, 2011, 10.3109/00498254.2011.573882

Thoroughly Validated Bayesian Estimator and Limited Sampling Strategy for Dose Individualization of Ganciclovir and Valganciclovir in Pediatric Transplant Recipients., , Clinical pharmacokinetics, 2021, 10.1007/s40262-021-01034-w

Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry, Lachatre, G, Dupuy, JL, Gaulier, JM, Lacassie, E, Rousseau, A, Lachatre, F, Marquet, P, Ragot, S, Journal of Chromatography B, 1999, 10.1016/S0378-4347(99)00452-1

Pesticide contamination of workers in vineyards in France, Marquet, P, Dulaurent, S, Rougetet, L, Jean, S, Lebailly, P, Baldi, I, Journal of Exposure Science and Environmental Epidemiology, 2006, 10.1038/sj.jea.7500443

Investigation of the intestinal absorption of immunosuppressive drugs using the human intestinal Caco-2 cell line, Marquet, P., Beneytout, J. L., Liagre, B., Boussera, B., Picard, N., Fundamental & Clinical Pharmacology, 2007

Bayesian estimation of mycophenolic acid in renal transplant patients, Paintaud, G., Autret-Leca, E., Lebranchu, Y., Debord, J., Buchler, M., Marquet, P., Bourgoin, H., Le Guellec, C., Fundamental & Clinical Pharmacology, 2001

Untitled, Rousseau, A, Marquet, P, Saint-Marcoux, F, Therapeutic Drug Monitoring, 2006, 10.1097/01.ftd.0000188016.36982.35

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs, Picard, Nicolas, Marquet, Pierre, Stojanova, Jana, Pouche, Lucie, Pharmacogenomics, 2016, 10.2217/pgs.15.169

Serotonin syndrome due to an overdose of moclobemide and clomipramine - A potentially life-threatening association, Gastinne, H, Lachatre, G, Roustan, J, Desachy, A, Marquet, P, Francois, B, Intensive Care Medicine, 1997, 10.1007/s001340050303

Changes in the metabolic composition of storage solution with prolonged cold ischemia of the uterus, , Journal of Assisted Reproduction and Genetics, 2019, 10.1007/s10815-019-01477-y

MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood., , Xenobiotica; the fate of foreign compounds in biological systems, 2020, 10.1080/00498254.2020.1813352

Tacrolimus population pharmacokinetics and bayesian estimation in tunisian renal transplant recipients, Saint-Marcoux, F., Marquet, P., Lakhal, M., Klouz, A., Jebari, H., Woillard, J. B., Gaies, E., Fundamental & Clinical Pharmacology, 2012

Anti-hepatitis C virus drugs and kidney, Loustaud-Ratti, V., Jacques, J., Marquet, P., Rousseau, A., Sautereau, D., Debette-Gratien, M., Essig, M., Carrier, P., World Journal of Hepatology, 2016, 10.4254/wjh.v8.i32.1343

Association analysis between polymorphisms in proteins of the m-TOR signaling pathway and sirolimus adverse effects in renal transplantation, Picard, N., Rostaing, L., Marquet, P., Kamar, N., Rousseau, A., Woillard, J. B., Therapeutic Drug Monitoring, 2011

Development of a population model and a bayesian estimator for Envarsus (R) in liver transplantation, Marquet, P., Saint-Marcoux, F., Monchaud, C., Debord, J., Woillard, J. B., Fundamental & Clinical Pharmacology, 2017

Determination of LSD and N-demethyl-LSD in urine by liquid chromatography coupled to electrospray ionization mass spectrometry, Lachatre, G, Dupuy, JL, Lotfi, H, Verneuil, B, Marquet, P, Hoja, H, Journal of Chromatography B, 1997, 10.1016/S0378-4347(97)00008-X

Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction, Thervet, E., Legendre, C., Beaune, P., Meria, P., Cassinat, B., Marquet, P., Rabant, M., Pallet, N., Anglicheau, D., Kidney International, 2006, 10.1038/sj.ki.5001649

Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique, Leblanc, JCY, Gamble, TN, Saint-Marcoux, F, Marquet, P, Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2003, 10.1016/S1570-0232(03)00071-0

High-dose buprenorphine fog treatment of opioid dependence, Marquet, P, Kintz, P, Strain, EC, Buprenorphine Therapy of Opiate Addiction, 2002

Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?, , Therapie, 2019, 10.1016/j.therap.2019.11.010

Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection., , American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, 10.1111/ajt.15959

A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators, , Clinical Pharmacokinetics, 2018, 10.1007/s40262-018-0646-5

Tacrolimus Exposure Prediction Using Machine Learning., , Clinical pharmacology and therapeutics, 2020, 10.1002/cpt.2123

A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil, Marquet, P, Le Guellec, C, Hoizey, G, Lebranchu, Y, Toupance, O, Le Meur, Y, Rousseau, A, Debord, J, Premaud, A, Clinical Pharmacokinetics, 2005

Multi-omics investigation of tacrolimus nephrotoxicity, Essig M, Marquet P, Arnion H, Barrot C, Pinault E, Sauvage F, Faucher Q, Aouad H, 2021, 10.1101/2021.07.29.454229

Pharmacological determinants of post-transplant lymphoproliferative disease (PTLD): feasibility of a large case-control study, Marquet, P., Essig, M., Rerolle, J., Roussel, H., Rousseau, A., Caillard, S., Stojanova, J., Fundamental & Clinical Pharmacology, 2011

Comment on "Population Pharmacokinetics of Mycophenolic Acid: An Update"., Marquet P, Debord J, Woillard JB, Clinical pharmacokinetics, 2018, 10.1007/s40262-018-0687-9

Significant Influence of Hematocrit on Tacrolimus Apparent Clearance in Renal Transplant Patients., Rousseau, Annick, Marquet, Pierre, Le Meur, Yannick, Turcant, Alain, Villemain, Florence, Olivier, Toupance, Hoizey, Guillaume, Rerolle, Jean-Philippe, Premaud, Aurelie, Benkali, Khaled, American Journal of Transplantation, 2009

Impact of Two Years of 50% Reduction of Cyclosporine Exposure in Stable Kidney Transplant Recipients Treated with Mycophenolate Mofetil without Corticosteroids on Renal Function- "Results at 60 Months of Follow-Up of a Multicenter Randomized Controlled Trial: The DICAM Study"., Godin, M., Benichou, J., Houivet, E., Francois, A., Marquet, P., Westeel, P. -F., Rerolle, J. -P., de Ligny, B. Hurault, Al Najjar, A., Thierry, A., Toupance, O., Etienne, I., American Journal of Transplantation, 2011

Recherche et innovation en santé : comment optimiser l’interface entre les startups/industries et les établissements de santé académiques ou non ?, , Therapie, 2019, 10.1016/j.therap.2019.11.006

Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients, Marquet, Pierre, Samuel, Didier, Sautereau, Denis, Loustaud-Ratti, Veronique, Sebagh, Mylene, Picard, Nicolas, Woillard, Jean-Baptiste, Debette-Gratien, Marilyne, Transplantation, 2016, 10.1097/TP.0000000000001394

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee, Wallemacq, Pierre, Wieland, Eberhard, Oellerich, Michael, Marquet, Pierre, Langman, Loralie J., Pawinski, Thomasz, Kunicki, Pawel K., Brunet, Merce, Holt, David W., Wang, Ping, Billaud, Elaine M., Christians, Uwe, Shipkova, Maria, Seger, Christoph, Therapeutic Drug Monitoring, 2016

Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography mass spectrometry, Lachatre, G, Raby, C, Buxeraud, J, Comby, F, Marquet, P, Rousseau, A, Journal of Chromatography B, 1997, 10.1016/S0378-4347(97)00052-2

Simultaneous determination of six dialkylphosphates in urine by liquid chromatography tandem mass spectrometry, Lachatre, G, Marquet, P, Saint-Marcoux, F, Dulaurent, S, Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2006, 10.1016/j.jchromb.2005.12.012

Automatic quantification of uracil and dihydrouracil in plasma., , Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, 10.1016/j.jchromb.2020.122038

Pharmacology of high-dose buprenorphine, Kintz, P, Marquet, P, Buprenorphine Therapy of Opiate Addiction, 2002

Decreased serum paraoxonase activity as a cardiovascular risk factor in chronic renal failure., LerouxRobert, C, Merle, L, Lachatre, G, Marquet, P, Charmes, JP, Debord, J, Dantoine, T, Journal of the American Society of Nephrology, 1997

Low mycophenolic acid area under the curve is associated with increased systemic lupus erythematosus activity, Amoura, Z., Lechat, P., Piette, J. C., Marquet, P., Cacoub, P., Costedoat-Chalumeau, N., Debord, J., Haroche, J., Hulot, J. S., Zahr, N., Fundamental & Clinical Pharmacology, 2008

Cost-Effectiveness Analysis of Individualized Mycophenolate Mofetil Dosing in Kidney Transplant Patients in the APOMYGRE Trial, Marquet, Pierre, Le Meur, Yannick, Vergnenegre, Alain, Villeneuve, Claire, Buchler, Mathias, Jacqz-Aigrain, Evelyne, Saivin, Sylvie, Debruyne, Daniele, Hary, Lionel, Compagnon, Patricia, Hoizey, Guillaume, Turcant, Alain, Loichot-Roselmac, Cecile, Venisse, Nicolas, Laroche, Marie-Laure, Rousseau, Annick, Transplantation, 2010, 10.1097/TP.0b013e3181d75952

Population Pharmacokinetic Modeling Approach to compare different vancomycin dose rates in premature neonates according to weight and serum creatinine values, Saint-Marcoux, F., Marquet, P., Guigonis, V., Neely, M., Lebreton, V., Casagrande, K., Nolain, P., Woillard, J. B., Fundamental & Clinical Pharmacology, 2015

Implication of efflux transporters and CYP3A on the transepithelial flux of mTOR inhibitors across human intestinal Caco-2 cell monolayers and interaction with Cyclosporine A, Marquet, P., Picard, N., Boussera, B., Lamoureux, F., Fundamental & Clinical Pharmacology, 2009

Analytical aspects of volatile substance abuse (VSA), Lachatre, G, Marquet, P, Sayer, H, Faict, T, Tonnay, V, Gaulier, JM, Journal of Forensic Sciences, 2003

A single Bayesian estimator for iohexol clearance estimation in ICU, liver failure and renal transplant patients., Woillard JB, Marquet P, Barin-Le Guellec C, Ehrmann S, Carrier P, Loustaud-Ratti V, Åsberg A, Salmon Gandonnière C, Destere A, British journal of clinical pharmacology, 2022, 10.1111/bcp.15197

Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale, Florent Di Meo, Pierre Marquet, Chantal Barin-Le Guellec, Nicolas Védrenne, Hélène Arnion, Quentin Faucher, Ágota Tóth, Angelika Janaszkiewicz, 2022, 10.1101/2022.07.14.500056

Evaluating Patients' Experiences Towards Their Immunosuppressive Treatment: A Way to Improve Adherence, Monchaud, C., Marquet, P., Zoughbi, J., Hegarat, S., Essig, M., Grau, M., Villeneuve, C., American Journal of Transplantation, 2017

Population pharmacokinetics of cyclosporin in lung transplant patients: mixed-effect modeling and development of a Bayesian estimator using NONMEM, Marquet, P, Bernard, N, Estenne, M, Debord, J, Rousseau, A, Saint-Marcoux, F, Therapeutic Drug Monitoring, 2003

A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation, Picard, Nicolas, Marquet, Pierre, Petersen, Britt-Sabina, Bouchet, Stephane, Gandia, Peggy, Merville, Pierre, Rostaing, Lionel, Kamar, Nassim, Rerolle, Jean-Phillippe, Le Meur, Yannick, Abraham, Julie, Essig, Marie, Villeneuve, Claire, Monchaud, Caroline, Woillard, Jean -Baptiste, Stojanova, Jana, Koitka, Matthias, Pouche, Lucie, Pharmacogenomics, 2016, 10.2217/pgs.15.181

Modulation of Monocyte Response by MicroRNA-15b/106a/374a During Antibody-mediated Rejection in Kidney Transplantation., Anglicheau D, Rabant M, Cagnard N, Aouni L, Morin L, Ménager M, Garcia-Paredes V, Sauvaget V, Benon A, Von Tokarski F, Van Loon E, Gazut S, Lamarthée B, Tinel C, Transplantation, 2023, 10.1097/tp.0000000000004393

Simultaneous determination of lidocaine and bupivacaine in human plasma: Application to pharmacokinetics, Lachatre, G, Feiss, P, BenRhaiem, M, Marquet, P, Dreyfuss, MF, Debord, J, Lotfi, H, Therapeutic Drug Monitoring, 1997, 10.1097/00007691-199704000-00007

Treatment of requests of dosages of pesticides in biological environments : some problems encountered frequently, Lachatre, G, Marquet, P, Gaulier, JM, Dulaurent, S, Acta Clinica Belgica, 2006

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure, Cattaneo, Dario, van Gelder, Teun, Kuypers, Dirk R., Marquet, Pierre, Miura, Masatomo, Vinks, Alexander A., Brunet, Merce, Staatz, Christine E., Saint-Marcoux, Franck, Tett, Susan E., Transplantation Reviews, 2011, 10.1016/j.trre.2010.06.001

Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis, Marquet, P, Thiry, P, Estenne, M, Vervier, I, Debord, J, Monchaud, C, Rousseau, A, Therapeutic Drug Monitoring, 2003, 10.1097/00007691-200302000-00004

Proximal Tubular Dysfunction Is Common After the First Year of Kidney Transplantation, Essig, M., Marquet, P., Aldigier, J. -C., Bodeau, S., Marin, B., Saint-Marcoux, F., Allard, J., Ensergueix, G., American Journal of Transplantation, 2015

Mycophenolate mofetil monitoring in kidney transplant recipients: A cost-effectiveness study, Le Meur, Y., Jacqz-Aigrain, E., Saivin, S., Debruyne, D., Turcant, A., Grima, M., Venisse, N., Hary, L., Compagnon, P., Hoizey, G., Vergnenegre, A., Marquet, P., Laroche, M. L., Therapeutic Drug Monitoring, 2007

Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry, Marquet, P, Tubiana-Mathieu, N, Dupuy, JL, Genet, D, Rousseau, A, Sauvage, FL, Ragot, S, Journal of Chromatography B, 2001, 10.1016/S0378-4347(00)00408-4

Concentration controled versus fixed dose of MMF in kidney transplant recipients: Preliminary results of a French multicenter randomized study., Marquet, P, Rerolle, JP, Szelag, JC, Thervet, E, Rostaing, L, Allard, C, Villemain, F, Caillard, S, Thierry, A, Westeel, PF, Etienne, I, Lavaud, S, Buchler, M, Le Meur, Y, American Journal of Transplantation, 2005

Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients, Paintaud, G, Marquet, P, Lebranchu, Y, Le Meur, Y, Buchler, M, Bourgoin, H, Le Guellec, C, Clinical Pharmacokinetics, 2004, 10.2165/00003088-200443040-00004

Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?, Lawson R, Marquet P, Picard N, Brossier C, Jardou M, Faucher Q, Frontiers in endocrinology, 2022, 10.3389/fendo.2022.898878

Polymorphisms of the mammalian target of rapamycin (mTOR) and gene expression in the lymphocytes of healthy volunteers, Marquet, P., Soudan, M. C., Woillard, J. B., Picard, N., Fundamental & Clinical Pharmacology, 2010

Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography mass spectrometry, Lachatre, G, Dupuy, JL, Lotfi, H, Verneuil, B, Marquet, P, Hoja, H, Journal of Analytical Toxicology, 1997

Pharmacokinetic Therapeutic Drug Monitoring of Advagraf in More Than 500 Adult Renal Transplant Patients, Using an Expert System Online, Woillard, J. B., Essig, M., Cassuto, E., Moulin, B., Kamar, N., Etienne, I., Rerolle, J. P., Saint-Marcoux, F., Monchaud, C., Bedu, A., Marquet, P., Therapeutic Drug Monitoring, 2018, 10.1097/ftd.0000000000000503

Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs, Marquet, P, Rousseau, A, Fundamental & Clinical Pharmacology, 2002, 10.1046/j.1472-8206.2002.00086.x

Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients., , British journal of clinical pharmacology, 2020, 10.1111/bcp.14261

Uterus tolerance to extended cold ischemic storage after auto-transplantation in ewes, Gauthier, T., Piccardo, A., Marquet, P., Yardin, C., Terro, F., Couquet, C., Lachatre, D., Mesturoux, L., Tholance, Y., Ponsonnard, S., Tricard, J., European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017, 10.1016/j.ejogrb.2017.05.013

General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints, Marquet, Pierre, Lachatre, Gerard, Gaulier, Jean-Michel, Saint-Marcoux, Franck, Picard, Nicolas, Sauvage, Francois-Ludovic, Journal of Separation Science, 2009, 10.1002/jssc.200900092

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation, Marquet, P, Legendre, C, Daly, A, Beaune, P, Tregouet, D, Laurent-Puig, P, Buchler, M, Touchard, G, Le Meur, Y, De Ligny, BH, Etienne, I, Thervet, E, Anglicheau, D, Clinical Pharmacology & Therapeutics, 2004, 10.1016/j.clpt.2004.01.009

Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers, Dostert, P, Homery, MC, Wodey, E, Marquet, P, Montestruc, F, Pecking, M, British Journal of Clinical Pharmacology, 2002, 10.1046/j.1365-2125.2002.01665.x

Multicenter evaluation of the roche total mycophenolic acid assay on COBAS INTEGRA (R) systems, Shaw, L., Oellerich, M., Engelmayer, J., Schmitz, G., Domke, I., Coffing, M. J., Liebisch, G., Marquet, P., Korecka, M., Figurski, M., Luthe, H., Therapeutic Drug Monitoring, 2007

Liquid chromatography electrospray mass spectrometry multiresidue determination of pesticides in apples and pears, Lachatre, G, Marquet, P, Vignaud, M, Daguet, JL, Dreyfuss, MF, Lacassie, E, Journal of Chromatography a, 1999, 10.1016/S0021-9673(98)00871-1

THE ACTIVITY OF ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANTATION IS REFLECTED BY ACTIVATED NATURAL KILLER CELL TRANSCRIPTS: THE BIOMARGIN STUDY, Naesens, M., Marquet, P., Essig, M., Gwinner, W., Anglicheau, D., Gazut, S., Yazdani, S., Transplant International, 2017

European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs, ESOT Advisory Comm Generic, van Gelder, Teun, Transplant International, 2011

In vitro LC-MS/MS cocktail strategy for the simultaneous evaluation of glucuronidation enzyme activities of human liver microsomes, Marquet, P., Sauvage, F. L., Picard, N., Rouguieg, K., Fundamental & Clinical Pharmacology, 2009

From small molecules to proteins: the same risks of misinterpretation of LC-MS/MS results, Gastinel, L. N., Marquet, P., Gagez, A. L., Sauvage, F. L., Therapeutic Drug Monitoring, 2011

Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: The example of tacrolimus., , Pharmacological research, 2021, 10.1016/j.phrs.2021.105578

Ribavirin therapeutic drug monitoring: why, when and how?, French Ribavirin Grp OPTIRIB, Marquet, Pierre, Gagnieu, Marie-Claude, Babany, Gerard, Loustaud-Ratti, Veronique, Stanke-Labesque, Francoise, Fundamental & Clinical Pharmacology, 2010, 10.1111/j.1472-8206.2009.00778.x

Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants, Marquet, Pierre, Rousseau, Annick, Caillard, Sophie, Stojanova, Jana, Pharmacological Research, 2011, 10.1016/j.phrs.2010.10.016

Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs, Haufroid, Vincent, Hesselink, Dennis A., Wallemacq, Pierre, van Gelder, Teun, Marquet, Pierre, Bergan, Stein, Picard, Nicolas, Therapeutic Drug Monitoring, 2016

Endogenous Metabolites-Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity., Barin-Le Guellec C, Marquet P, Andrès CR, Choquet S, Gyan E, Berthelot A, Woillard JB, Muhrez K, Martinez D, Clinical pharmacology and therapeutics, 2018, 10.1002/cpt.1008

Monitoring of adherence to calcineurin inhibitors using their longitudinal exposures in kidney transplant patients, Premaud, A., Rousseau, A., Marquet, P., Essig, M., Monchaud, C., Villeneuve, C., Stamenic, D., Fundamental & Clinical Pharmacology, 2017

Population Pharmacokinetic Modeling Approach to compare different amikacin dose rates in children with cystic fibrosis: are we efficient enough?, Woillard, J. B., Marquet, P., Saint-Marcoux, F., Bui, S., Woloch, C., Bouchet, S., Lakdhari, A., Fundamental & Clinical Pharmacology, 2016

Identification and quantitation of six non-depolarizing neuromuscular blocking agents by LC-MS in biological fluids, Lachatre, U, Gaulier, JM, Dupuy, JL, Marquet, P, Quintela, O, Sayer, H, Journal of Analytical Toxicology, 2004

Mycophenolic acid exposure prediction using machine learning., , Clinical pharmacology and therapeutics, 2021, 10.1002/cpt.2216

Stability of Ribavirin Concentrations Depending on the Type of Blood Collection Tube and Preanalytical Conditions, Lachatre, Gerard, Rousseau, Annick, Babany, Gerard, Loustaud-Ratti, Veronique, Sauvage, Francois-Ludovic, Marquet, Pierre, Therapeutic Drug Monitoring, 2010, 10.1097/FTD.0b013e3181d3f686

How to improve clinical research performances in France?, Unger, Philippe, Trinquet, Francoise, Thuillez, Christian, Rossignol, Patrick, Reynier, Jean Charles, Rascol, Olivier, Postaire, Eric, Pathak, Atul, Ogier, Emmanuel, Marquet, Pierre, Marey, Christine, Maisonneuve, Pascale, Le Thiec, Francoise, Le Coent, Remi, Joubert, Jean Michel, Gueyffier, Francois, Gaultier, Claude, Dubray, Claude, Devilliers, Elisabeth, Deregnaucourt, Jean, Decousus, Herve, Cournot, Antoine, Bey, Pierre, Behier, Jehan Michel, Ballet, Francois, Round Table No. 4, Giens XXIII, Pletan, Yannick, Diebolt, Vincent, Therapie, 2008, 10.2515/therapie:2008045

How Tacrolimus Pharmacodynamics of the Patients in the Waiting List Could Influence Post Liver Transplantation Profile?, Marquet, Pierre, Woillard, Jean-Baptiste, Tourino, Cristina, Lens, Daniela, Gerona, Solange, Esperon, Patricia, Pouche, Lucie, Noceti, Ofelia M., Transplantation, 2016

Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones, Galen, FX, Chassain, AP, Marquet, P, Lac, G, Journal of Applied Physiology, 1999

APOMYGRE: a multicenter trial which validates mycophenolate mofetil therapeutic drug monitoring in de novo kidney transplant recipients, Le Meur, Y., Jacqz-Aigrain, E., Saivin, S., Debruyne, D., Turcant, A., Loichot, C., Hary, L., Compagnon, P., Hoizey, G., Debord, J., Rousseau, A., Marquet, P., Fundamental & Clinical Pharmacology, 2007

Identification of the UDP-Glueuronosyltransferase (UGT) Isoforms involved in Buprenorphine Glucuronidation and Evaluation of the Inhibitory Potential of this Drug on UGTs, Picard, N., Marquet, P., Comte, J-H., Sauvage, F-L., Rouguieg, K., Therapeutic Drug Monitoring, 2009

[A specific dosage method for the analysis of 24 antidepressants using gas chromatography-mass spectrometry (GC/SM)]., Lachatre, G, Marquet, P, Gaulier, J M, Ragot, S, Lacassie, E, Acta clinica Belgica, 1999

Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters Cross-sectional study, Stankevicius, E., Kadusevicius, E., Marquet, P., Saint-Marcoux, F., Noreikaite, A., Medicine, 2017, 10.1097/md.0000000000006469

Adaptation of the implementation of good clinical practices depending on the characteristics of some research, Participants Table Ronde Giens 21, Best, Nicolas, Courcier-Duplantier, Soizic, Bertoye, Pierre-Henri, Therapie, 2006, 10.2515/therapie:2006052

Phase II metabolites of mycophenolic acid: In vitro/in vivo characterization and pharmacokinetics in renal transplants, Marquet, P, Ratanasavangh, D, Le Meur, Y, Rousseau, A, Premaud, A, Picard, N, Therapeutic Drug Monitoring, 2003

Enteric-coated mycophenolate sodium in de novo pediatric renal transplant patients, Lemay, Djamila, Chaouche-Teyara, Kamel, Marquet, Pierre, Dehennault, Maud, Foulard, Michel, Cailliez, Mathilde, Tsimaratos, Michel, Lapeyraque, Anne-Laure, Loirat, Chantal, Charbit, Marina, Niaudet, Patrick, Pediatric Nephrology, 2009, 10.1007/s00467-008-1031-7

Donor P-gp Polymorphisms Strongly Influence Renal Function and Graft Loss in a Cohort of Renal Transplant Recipients on Cyclosporine Therapy in a Long-Term Follow-Up, Marquet, P., Le Meur, Y., Drouet, M., Essig, M., Munteanu, E., Guillaudeau, A., Rousseau, A., Picard, N., Rerolle, J-P, Woillard, J-B, Clinical Pharmacology & Therapeutics, 2010, 10.1038/clpt.2010.62

Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus, Gastinel, L. N., Marquet, P., Sauvage, F. L., Essig, M., Mestre, E., Lamoureux, F., Journal of Proteomics, 2011, 10.1016/j.jprot.2011.09.005

Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography, Lachatre, G, Rabatel, JF, Marquet, P, Gaulier, JM, Lacassie, E, Journal of Chromatography B, 2000, 10.1016/S0378-4347(00)00159-6

The Hepatic Organic Anion Transporting Polypeptides (OATP) Uptake Transporters are Involved in Mycophenolic Acid Pharmacokinetics: Effect of Major Genetic Variants on Drug Exposure in Kidney Transplants, Giacomini, K. M., Marquet, P., Le Meur, Y., Lebranchu, Y., Woillard, J-B., Yee, S. W., Picard, N., Therapeutic Drug Monitoring, 2009

Relationship between psychotropic drugs and thyroid function: A review (vol 149, pg 127, 1998), Lachatre, G, Buxeraud, J, Raby, C, Rousseau, A, Marquet, P, Sauvage, MF, Toxicology and Applied Pharmacology, 1998, 10.1006/taap.1998.8531

An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine, Marquet, P, Laurentie, M, Manceau, J, Ragot, S, Gicquel, M, Rousseau, A, Premaud, A, Toxicology and Applied Pharmacology, 2002, 10.1006/taap.2002.9467

Letter to the Editor: ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology, Marquet, Pierre, Sauvage, Francois-Ludovic, Analytical and Bioanalytical Chemistry, 2010, 10.1007/s00216-010-3451-z

PESTICIDE-RESIDUE DETERMINATION IN HONEY AND APPLES BY HPLC AND GC, LACHATRE, G, DAGUET, JL, DEBORD, J, MARQUET, P, LOTFI, H, DREYFUSS, MF, Analusis, 1994

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin, RIBAJUSTE Group, Trepo, Christian, Marquet, Pierre, Zublena, Iresne, Picard, Nicolas, Lunel-Fabiani, Francoise, Silvain, Christine, Dao, Thong, Tran, Albert, Gagnieu, Marie-Claude, Deny, Paul, Alain, Sophie, Rousseau, Annick, Pradat, Pierre, Thevenon, Sylvie, Maynard, Marianne, Loustaud-Ratti, Veronique, Therapeutic Drug Monitoring, 2016, 10.1097/FTD.0000000000000332

First-Line Toxicological Screening with Fully Automated Extraction., , Journal of analytical toxicology, 2021, 10.1093/jat/bkaa075

Determination of trimeprazine and its main metabolites in mouse serum and thyroid by liquid chromatography electrospray mass spectrometry, Lachatre, G, Raby, C, Buxeraud, J, Rousseau, A, Marquet, P, Sauvage, MF, Journal of Liquid Chromatography & Related Technologies, 1998, 10.1080/10826079808001266

Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography mass spectrometry, Lachatre, G, Faubert, H, Battu, C, Lacassie, E, Marquet, P, Journal of Chromatography B, 1997, 10.1016/S0378-4347(97)00318-6

Characterization of a new metabolic pathway for buprenorphine, Marquet, P, Cresteil, T, Picard, N, Therapeutic Drug Monitoring, 2003

Design of maximum a posteriori (MAP) Bayesian estimators for oral cyclosporin pharmacokinetics forecasting in de novo renal transplant patients, Marquet, P, Hoizey, G, Toupance, O, Le Meur, Y, Rousseau, A, Debord, J, Saint-Marcoux, F, Therapeutic Drug Monitoring, 2003

Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations., , European journal of clinical pharmacology, 2020, 10.1007/s00228-020-02867-3

Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology, Marquet, P, Therapeutic Drug Monitoring, 2002, 10.1097/00007691-200204000-00008

Pretransplantation calcineurin activity: towards individualized therapy?, Marquet, Pierre, Liver International, 2009, 10.1111/j.1478-3231.2009.02146.x

Biomarker research in urinary peptidoma for early diagnosis of renal graft dysfunction, Gastinel, L. N., Essig, M., Rerolle, J. P., Le Meur, Y., Marquet, P., Benkali, K., Bulletin Du Cancer, 2008

Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients: Comparison of Two Approaches, Saint-Marcoux, F., Marquet, P., Sinnasse-Raymond, G., Neely, M., Debord, J., Rousseau, A., Premaud, A., Woillard, J-B, Youdarene, R., Journal of Heart and Lung Transplantation, 2013

A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen, , American Journal of Transplantation, 2018, 10.1111/ajt.14894

Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology., Naesens M, Koshy P, Cortés Calabuig Á, Tinel C, Callemeyn J, Giral M, Danger R, Brouard S, Van Craenenbroeck AH, de Loor H, Lamarthée B, Van Loon E, Kidney international, 2022, 10.1016/j.kint.2022.03.026

New rave drugs: Ketamine and prolintane, Lachatre, G, Marquet, P, Pradeille, JL, Canal, M, Gaulier, JM, Acta Clinica Belgica, 2002

[History of pharmacology-toxicology in Limoges]., au nom de la pharmacologie-toxicologie Limousine, Lachâtre G, Merle L, Laroche ML, Marquet P, Therapie, 2023, 10.1016/j.therap.2023.02.003

Effects of Ischemia-Reperfusion on Tubular Cell Membrane Transporters and Consequences in Kidney Transplantation., , Journal of clinical medicine, 2020, 10.3390/jcm9082610

New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis., Monchaud C, Saint-Marcoux F, Marquet P, Debette-Gratien M, Rerolle JP, El Balkhi S, Tafzi N, Rosé G, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2023, 10.1016/j.jchromb.2023.123721

Pharmacokinetic Modeling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving the Tacrolimus Once-Daily Formulation, Marquet, Pierre, Rousseau, Annick, Undre, Nasrullah, Debord, Jean, Saint-Marcoux, Franck, Therapeutic Drug Monitoring, 2010, 10.1097/FTD.0b013e3181cc70db

In silico pharmacology: Drug membrane partitioning and crossing, Trouillas, Patrick, Otyepka, Michal, Marquet, Pierre, Paloncyova, Marketa, Chantemargue, Benjamin, Ossman, Tahani, Berka, Karel, Fabre, Gabin, Di Meo, Florent, Pharmacological Research, 2016, 10.1016/j.phrs.2016.06.030

Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms, , Pharmacological Research, 2018, 10.1016/j.phrs.2018.02.029

Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial., Koch A, Fischereder M, Arns W, Matz M, Budde K, Marquet P, Anglicheau D, Van Loon E, Naesens M, Metzger J, Khalifa AA, Braesen JH, Karch A, Gwinner W, Transplantation direct, 2022, 10.1097/txd.0000000000001316

Pharmacokinetic Optimization of Immunosuppressive Therapy in Thoracic Transplantation: Part II, Marquet, Pierre, Monchaud, Caroline, Clinical Pharmacokinetics, 2009

In-source CID mass spectral libraries for the "general unknown" screening of drugs and toxicants, Lachatre, G, Lacassie, E, Venisse, N, Marquet, P, Analusis, 2000, 10.1051/analusis:2000280925

Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data., Aouam, Karim, Saint-Marcoux, Franck, Marquet, Pierre, Boughattas, Naceur, Chaabane, Amel, Debord, Jean, Woillard, Jean Baptiste, Ben Fredj, Nadia, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2016

SILAC quantitative proteomic analysis of calcineurin inhibitors-induced toxicity in a human kidney cell line reveals different toxicity profiles between cyclosporine and tacrolimus, Gastinel, L. N., Essig, M., Sauvage, F. L., Marquet, P., Mestre, E., Lamoureux, F., Therapeutic Drug Monitoring, 2011

Adherence Time-Profiles of Renal Transplant Patients During the Three First Years Post-Transplantation, Rousseau, A., Marquet, P., Kamar, N., Merville, P., Fruit, D., Bouchet, S., Lacroix, I., Coubret, A., Laroche, M. -L., Monchaud, C., Essig, M., Villeneuve, C., American Journal of Transplantation, 2015

Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography-diode array detection, Marquet, P, Lachatre, G, Saint-Marcoux, F, Journal of the American Society For Mass Spectrometry, 2003, 10.1016/S1044-0305(02)00801-2

Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment, OPTIRIB Grp, Marquet, Pierre, Sautereau, Denis, Pinta, Alexandrina, Zarski, Jean-Pierre, Di Martino, Vincent, Pol, Stanislas, Bourliere, Marc, De Ledinghen, Victor, Trepo, Christian, Alain, Sophie, Babany, Gerard, Maynard, Marianne, Rousseau, Annick, Carrier, Paul, Loustaud-Ratti, Veronique, Digestive and Liver Disease, 2011, 10.1016/j.dld.2011.04.002

General unknown screening procedure using liquid chromatography-linear ion trap tandem mass spectrometry: Application to a tricky case, Marquet, Pierre, Lachatre, Gerard, Gaulier, Jean-Michel, Saint-Marcoux, Franck, Sauvage, Francois-Ludovic, Therapeutic Drug Monitoring, 2007

Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: Comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry, Marquet, P, Picard, N, Rousseau, A, Premaud, A, Therapeutic Drug Monitoring, 2006

Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation, Marquet, P, Dantoine, T, Debord, J, David, OJ, Leger, F, Rousseau, A, Monchaud, C, European Journal of Clinical Pharmacology, 2003, 10.1007/s00228-003-0559-5

Mapping cyclosporine-induced changes in protein secretion by renal cells using stable isotope labeling with amino acids in cell culture (SILAC), Essig, M., Marquet, P., Mestre, E., Gastinel, L. N., Lamoureux, F., Journal of Proteomics, 2012, 10.1016/j.jprot.2012.04.024

Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients, Picard, Nicolas, Trouillas, Patrick, Marquet, Pierre, Woillard, Jean-Baptiste, Otyepka, Michal, Fabre, Gabin, Kaminski, Hannah, Rostaing, Lionel, Kamar, Nassim, Rerolle, Jean-Philippe, Essig, Marie, Saint-Marcoux, Franck, Ossman, Tahani, Billat, Pierre-Andre, Pharmacological Research, 2016, 10.1016/j.phrs.2016.07.012

Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on acyl-MPAG production in vitro and in adult renal transplant patients, Marquet, Pierre, Le Meur, Yann, Rerolle, Jean-Philippe, Picard, Nicolas, Djebli, Nassim, Pharmacogenetics and Genomics, 2007

Pharmacogenetic determinants of aromatase inhibitors pharmacokinetics and side effects: 6-month results of the adjuvant breast cancer longitudinal PHACS study (NCT01127295), Evrard, A., Chatelut, E., Roche, H., Le Morvan, V., Mbatchi, L., Massoubre, A., Ellis, S., Levasseur, N., Despax, R., Solassol, I., Tafzi, N., Robert, J., White-Koning, M., Pinguet, F., Marquet, P., Thomas, F., Cancer Research, 2018

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART, COPHAR2 ANRS 111 Study Grp, Mentre, France, Duval, Xavier, Salmon-Ceron, Dominique, Rey, Elisabeth, Auleley, Solange, Tran, Agnes, Panhard, Xaviere, Treluyer, Jean-Marc, Bertrand, Julie, European Journal of Clinical Pharmacology, 2009, 10.1007/s00228-009-0660-5

Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards, Kamar, Nassim, Saint-Marcoux, Franck, Lavit, Michel, Josse, Anne-Gaelle, Marquet, Pierre, Cointault, Olivier, Rostaing, Lionel, Transplant International, 2010, 10.1111/j.1432-2277.2009.00965.x

Pharmacokinetics of Mycophenolate Mofetil (MMF) in Lung Transplantation: Comparison with Renal Transplantation, Rousseau, A., Marquet, P., Estenne, M., Knoop, C., Guillemain, R., Stern, M., Dromer, C., Reynaud-Gaubert, M., Kessler, R., Pison, C., Premaud, A., Monchaud, C., de Winter, B. C. M., Journal of Heart and Lung Transplantation, 2011

Towards therapeutic drug monitoring of everolimus? Results of an exploratory study of the dose-exposure relationships, Woillard, J. B., Marquet, P., Tubiana-Mathieu, N., Picard, N., Laroche, M. L., Monchaud, C., Saint-Marcoux, F., Falkowski, S., Deppenweiler, M., Fundamental & Clinical Pharmacology, 2017

Preliminary evaluation of a nanoLC MALDI-Tof/Tof spectrometry method for the investigation of urine biomarkers of mdney allograft acute rejection, Gastinel, Louis N., Le Meur, Yannick, Marquet, Pierre, Benkali, Khaled, Therapeutic Drug Monitoring, 2007

Towards therapeutic drug monitoring of mycophenolic acid in mucous membrane pemphigoid: A retrospective single-centre study., , Fundamental & clinical pharmacology, 2021, 10.1111/fcp.12688

Comparison of dose proposed by an a priori population pharmacokinetic tool with clinician empirical dosing for vancomycine in premature neonates, Woillard, J. B., Marquet, P., Guigonis, V., Casagrande, K., Woloch, C., Saint-Marcoux, F., Grine, J., Fourgeaud, J., Fundamental & Clinical Pharmacology, 2016

[Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects]., Marquet, P, Acta clinica Belgica, 1999

Active or passive maternal smoking increases the risk of low birth weight or preterm delivery: Benefits of cessation and tobacco control policies, Yves Aubard, Daniel Thomas, Tristan Gauthier, Pierre Marquet, Conchita Delcroix-Gomez, Michel-Henri Delcroix, Tobacco Induced Diseases, 2023, 10.18332/tid/156854

Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry, Marquet, Pierre, Gastinel, Louis Noel, Sauvage, Francois-Ludovic, Journal of Chromatography a, 2012, 10.1016/j.chroma.2012.04.006

Pharmacokinetics of cyclosporine and development of a Bayesian estimator in heart, lung and renal transplant patients: A Nonmem analysis, Rousseau, A, Marquet, P, Saint-Marcoux, F, Therapeutic Drug Monitoring, 2005

Nonparametric Approach for Population Pharmacokinetic Study of Tacrolimus in Heart Transplant Patients, Saint-Marcoux, F., Marquet, P., Fruit, D., Woillard, J. B., Youdarene, R., Therapeutic Drug Monitoring, 2013

Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients, Marquet, Pierre, Pouche, Lucie, Youdarene, Rym, Monchaud, Caroline, Saint-Marcoux, Franck, Woillard, Jean-Baptiste, Pharmacological Research, 2015, 10.1016/j.phrs.2015.07.012

The European Association for Clinical Pharmacology and Therapeutics—25 years’ young and going strong, , European Journal of Clinical Pharmacology, 2019, 10.1007/s00228-019-02690-5

Application of a gamma model of absorption to oral cyclosporin, Le Guellec, C, Lachatre, G, Buchler, M, Le Meur, Y, Harel, M, Risco, E, Debord, J, Clinical Pharmacokinetics, 2001, 10.2165/00003088-200140050-00004

Development and Evaluation of a Simulation Procedure to Take Into Account Various Assays for the Bayesian Dose Adjustment of Tacrolimus, Marquet, Pierre, Rousseau, Annick, Rostaing, Lionel, Kamar, Nassim, Labalette, Myriam, Parant, Francois, Debord, Jean, Saint-Marcoux, Franck, Therapeutic Drug Monitoring, 2011, 10.1097/FTD.0b013e31820d6ef7

Therapeutic drug monitoring: Analytical, pharmacokinetic and clinical aspects, Marquet, P, Acta Clinica Belgica, 1999

Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies, Marquet, P, Estenne, M, Rousseau, A, Thiry, P, Debord, J, Knoop, C, Saint-Marcoux, F, Clinical Pharmacokinetics, 2005, 10.2165/00003088-200544120-00010

Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney, Essig, Marie, Marquet, Pierre, Mestre, Elodie, Descazeaud, Virginie, Journal of Cellular and Molecular Medicine, 2012, 10.1111/j.1582-4934.2011.01398.x

Decrease of serum paraoxonase activity in chronic renal failure, Leroux-Robert, C, Lachatre, G, Marquet, P, Merle, L, Charmes, JP, Debord, J, Dantoine, TF, Journal of the American Society of Nephrology, 1998

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study, Picard, N., Marquet, P., Rouguieg-Malki, K., Thalamas, C., Guimbaud, R., Smith, D., Pariente, A., Terrebonne, E., Tubiana-Mathieu, N., Postil, D., Woillard, J. B., Falkowski, S., Bmc Cancer, 2017, 10.1186/s12885-017-3728-0

ACTIVATED NATURAL KILLER CELL TRANSCRIPTS PREDICT GRAFT OUTCOME IN KIDNEY TRANSPLANTATION: THE BIOMARGIN STUDY, Naesens, M., Marquet, P., Essig, M., Gwinner, W., Anglicheau, D., Gazut, S., Yazdani, S., Transplant International, 2017

Therapeutic education as a tool to improve patient-reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study., Monchaud C, Marquet P, Thierry A, Büchler M, Kamar N, Esposito L, Etienne I, Westeel PF, Couzi L, Rerolle JP, Villeneuve C, Transplant international : official journal of the European Society for Organ Transplantation, 2021, 10.1111/tri.14127

Evaluation of Experiences with Immunosuppressive Drugs in Transplantation: Validation of the MESI Scale in French, Monchaud, C., Marquet, P., Debette-Gratien, M., Pison, C., Epailly, E., Etienne, I., Essig, M., Knoop, C., Woillard, J. B., Villeneuve, C., Pharmaceutical Medicine, 2017, 10.1007/s40290-017-0207-5

Cyclosporine A inhibits MRTF-SRF signaling through Na+/K+ ATPase inhibition and actin remodeling., , FASEB bioAdvances, 2019, 10.1096/fba.2019-00027

Rheumatoid factor interference in a tacrolimus immunoassay., Fortuny Marques, Regina, Riesco Prieto, Maria, Barcelo Bennasar, Antonia, Castanyer Puig, Bartomeu, Ferrer, Joana Maria, Marquet, Pierre, Barcelo Martin, Bernardi, Therapeutic drug monitoring, 2009, 10.1097/FTD.0b013e3181c01da1

Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome, Marquet, P., Compagnon, P., Broux, F., Bouchet, S., Libert, F., Harambat, J., Bessenay, L., Parant, F., Ranchin, B., Gandia, P., Decramer, S., Guigonis, V., Saint-Marcoux, F., Pharmacological Research, 2011, 10.1016/j.phrs.2011.01.009

Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C0 and AUC., , Medicine, 2020, 10.1097/md.0000000000019441

Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring, Marquet, P, Lachatre, G, Le Meur, Y, Rousseau, A, Premaud, A, Therapeutic Drug Monitoring, 2004

TDM of mycophenolate mofetil co-administered with tacrolimus in kidney graft recipients; Experience using the free ISBA website providing Bayesian dose adjustment, Bentue-Ferrer, Daniele, Marquet, Pierre, LePogamp, Patrick, Rivalan, Joseph, Frouget, Thierry, Morin, Marie-Pascale, Saint-Marcolix, Franck, Tribut, Olivier, Therapeutic Drug Monitoring, 2007

The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation, Marquet, Pierre, Picard, Nicolas, Expert Opinion on Drug Metabolism & Toxicology, 2011, 10.1517/17425255.2011.570260

Immunosuppressant quantification in intravenous microdialysate - towards novel quasi-continuous therapeutic drug monitoring in transplanted patients., , Clinical chemistry and laboratory medicine, 2020, 10.1515/cclm-2020-1542

Cyclosporine A inhibits MRTF-SRF signalling through Na+/K+ ATPase inhibition & Actin remodelling, Essig M, Marquet P, Sauvage F, Di Meo F, Arnion H, Čechová P, Faucher Q, Burat B, 2018, 10.1101/492843

Feasibility and Performance of Therapeutic Drug Monitoring of Mycophenolate Mofetil Monotherapy in Liver Transplant, Marquet, Pierre, Duvoux, Christophe, Lamarque, Catherine, Transplantation, 2016

INDIVIDUALIZING TRANSPLANT THERAPY, Asberg, A., Marquet, P., Individualized Drug Therapy for Patients: Basic Foundations, Relevant Software and Clinical Applications, 2017, 10.1016/b978-0-12-803348-7.00016-2

Identification of factors influencing mycophenolic acid area under the curve in systemic lupus erythematosus, Amoura, Z., Hulot, J. S., Piette, J. C., Funck-Brentano, C., Marquet, P., Haroche, J., Arnaud, L., Zahr, N., Fundamental & Clinical Pharmacology, 2010

Population pharmacokinetics and Bayesian estimation of mycophenolate mofetil in patients with autoimmune hepatitis., Prémaud A, Marquet P, Rousseau A, Woillard JB, Nanga TM, British journal of clinical pharmacology, 2022, 10.1111/bcp.15389

Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry, Farinotti, R, Davrinche, C, Soursac, M, Marquet, P, Baud-Camus, F, Journal of Chromatography B, 2001, 10.1016/S0378-4347(01)00246-8

Uterine allotransplantation in ewes using an aortocava patch, Aubard, Y., Essig, M., Cornuejols, M. J., Couquet, C., Plainard, X., Pommepuy, I., Marquet, P., Piver, P., Saint Marcoux, F., Maubon, A., Fourcade, L., Bertin, F., Gauthier, T., Human Reproduction, 2011, 10.1093/humrep/der288

Buprenorphine poisoning in drug abusers on substitution therapy: 29 non-fatal and 20 fatal cases, Ludes, B, Jaeger, A, Petit, G, Pepin, G, Marquet, P, Ghysel, MH, Deveaux, M, Kintz, P, Kopferschmitt, J, Flesch, F, Tournoud, C, Tracqui, A, Presse Medicale, 1998

Relationship between exposure variability to calcineurin inhibitors over time and onset of infection in renal transplant patients, Monchaud, C., Marquet, P., Rousseau, A., Laroche, M. L., Bouchet, S., Coubret, A., Gandia, P., Villeneuve, C., Fundamental & Clinical Pharmacology, 2016

COUNTERPOINT - Is Pharmacokinetic or Pharmacodynamic Monitoring of Calcineurin Inhibition Therapy Necessary?, Marquet, Pierre, Clinical Chemistry, 2010, 10.1373/clinchem.2009.138693

Uterus human leucocyte antigen expression in the perspective of transplantation., Drouet M, Marquet P, Aubard Y, Piver P, Pacha AF, Bibes R, Essig M, Guillaudeau A, Filloux M, Gauthier T, The journal of obstetrics and gynaecology research, 2016, 10.1111/jog.13107

Cytochrome P450 3A5 polymorphism significantly influences sirolimus oral clearance in de novo renal transplant recipients without calcineurin inhibitors, Marquet, P, Rousseau, A, Hoizey, G, Toupance, O, Le Meury, Y, Djebli, N, Therapeutic Drug Monitoring, 2005, 10.1097/00007691-200504000-00155

Optimized population pharmacokinetic model of cyclosporin in stable renal transplant patients., Marquet, P, Buchler, M, Le Meur, Y, Debord, J, Saint-Marcoux, F, Leger, F, Rousseau, A, Therapeutic Drug Monitoring, 2003

[Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus]., , Therapie, 2020, 10.1016/j.therap.2020.06.004

Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation, Marquet, Pierre, Kantelip, Jean-Pierre, Deconinck, Eric, Legrand, Faezeh, Larosa, Fabrice, Debord, Jean, Royer, Bernard, Saint-Marcoux, Franck, Clinical Pharmacokinetics, 2009

LC-MS/MS systematic toxicological analysis: Comparison of MS/MS spectra obtained with different instruments and settings, Marquet, P, Lachatre, G, Jansen, R, Clinical Biochemistry, 2005, 10.1016/j.clinbiochem.2004.11.003

Multiresidue determination method for organophosphorus pesticides in serum and whole blood by gas chromatography-mass-selective detection, Lachatre, G, Daguet, JL, Marquet, P, Gaulier, JM, Dreyfuss, MF, Lacassie, E, Journal of Chromatography B, 2001, 10.1016/S0378-4347(01)00211-0

A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum, Marquet, P, Lachatre, G, Gaulier, JM, Sauvage, FL, Therapeutic Drug Monitoring, 2006, 10.1097/01.ftd.0000194026.04483.c3

Development of a non-parametric population model and a bayesian estimator for tacrolimus in renal Tunisian transplant patients, Woillard, J. B., Marquet, P., Debord, J., Trabelsi, S., Gaies, E., Ben Sassi, M., Fundamental & Clinical Pharmacology, 2017

Pharmacokinetic modelling of raltegravir in HIV patients, Clementi, E., Marquet, P., Baldelli, S., Parinaud, A. S., Cattaneo, D., Saint-Marcoux, F., Therapeutic Drug Monitoring, 2011

Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs, Meyer, Eric J., Marquet, Pierre, Renjen, Varun, van Gelder, Teun, Wallemacq, Pierre, Clarke, William, Langman, Loralie J., Vinks, Alexander A., Christians, Uwe, Therapeutic Drug Monitoring, 2015, 10.1097/FTD.0000000000000205

Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry, Picard, Nicolas, Marquet, Pierre, Sauvage, Francois-Ludovic, Rouguieg-Malki, Koukeb, Gagez, Anne-Laure, Analytical Biochemistry, 2012, 10.1016/j.ab.2012.04.031

Identification of Drug Metabolites Through Routine Application of a LC-MS/MS General Unknown Screening Procedure in Forensic Toxicology, Marquet, Pierre, Lachatre, Gerard, Gaulier, Jean-Michel, Saint-Marcoux, Franck, Picard, Nicolas, Sauvage, Francois-Ludovic, Therapeutic Drug Monitoring, 2009

Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma, Oellerich, Michael, Luthe, Hilmar, Streit, Frank, Domke, Ingrid, Coffing, Mary Jane, Schmitz, Gerd, Liebisch, Gerhard, Shaw, Leslie M., Marquet, Pierre, Brandhorst, Gunnar, Therapeutic Drug Monitoring, 2008

The EPIGREN study: validation of collection tools in a French cohort of renal transplant patients, Laroche, M. L., Marquet, P., Rostaing, L., Merville, P., Essig, M., Villeneuve, C., Rousseau, A., Fruit, D., Fundamental & Clinical Pharmacology, 2013

Development of a Composite Endpoint (CEP) for Clinical Trials on Immunosuppressants (IS) in Lung Transplantation, Marquet, P., Estenne, M., Marin, B., Monchaud, C., Journal of Heart and Lung Transplantation, 2011

Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography mass spectrometry with electrospray ionization, Lachatre, G, Penicaut, B, Dupuy, JL, Lotfi, H, Verneuil, B, Marquet, P, Hoja, H, Journal of Chromatography B, 1997, 10.1016/S0378-4347(96)00294-0

BREATHS SOUNDS, MARQUET, P, Revue Des Maladies Respiratoires, 1995

Tacrolimus population pharmacokinetics analysis and Bayesian estimation in renal transplant recipients, Rousseau, A., Marquet, P., Turcant, A., Villemain, F., Toupance, O., Hoizey, G., Rerolle, J. P., Picard, N., Premaud, A., Le Meur, Y., Benkali, K., Fundamental & Clinical Pharmacology, 2009

Analyses of AUC(0-12) and C0 Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus., , Journal of clinical medicine, 2020, 10.3390/jcm9123903

Development and Validation of Multiple Linear Regression Formulas and a Bayesian Estimator for Mycophenolic Acid Long Term Therapeutic Drug Monitoring, Wallemacq, P., Verbeeck, R. K., Marquet, P., Cumps, J., Senessael, J. J., Bosmans, J. L., Rousseau, A., Musuamba, F., Therapeutic Drug Monitoring, 2009

Population pharmacokinetic model and Bayesian estimator of a generic formulation of cyclosporine in Tunisian renal transplant patients, Saint-Marcoux, F., Marquet, P., Lakhal, M., Klouz, A., Jebari, H., Woillard, J. B., Gaies, E., Fundamental & Clinical Pharmacology, 2012

Influence of sampling-time error on cyclosporine measurements nominally at 2 hours after administration, Marquet, P, Debord, J, Knoop, C, Estenne, M, Le Meur, Y, Rousseau, A, Saint-Marcoux, F, Clinical Chemistry, 2003, 10.1373/49.5.813

Uterus transplantation. Current situation, Aubard, Y., Essig, M., Laskar, M., Gardet, E., Drouet, M., Guillaudeau, A., Pichon, N., Marquet, P., Mesnard, C., Piver, P., Gauthier, T., Gynecologie Obstetrique & Fertilite, 2012, 10.1016/j.gyobfe.2012.09.011

Study of the association of glucuroconjugation enzyme polymorphism and xenobiotic transport proteins in patients suffering from colorectal cancer, Marquet, P., Durand, K., Labrousse, F., Rousseau, A., Picard, N., Rouguieg, W., Bulletin Du Cancer, 2008

Assessment of pesticide exposure in vineyard workers, Brochard, P, Marquet, P, Dulaurent, S, Ducamp, S, Rolland, P, Balid, I, Epidemiology, 2002

[Therapeutic drug monitoring]., Zahr, Noel, Verstuyft, Celine, Urien, Saik, Venisse, Nicolas, Turcant, Alain, Tribut, Olivier, Treluyer, Jean-Marc, Tittier, Karine, Taburet, Anne-Marie, Stanke-Labesque, Francoise, Simon, Nicolas, Sequier-Ubeaud, Genevieve, Sampol-Manos, Emmanuelle, Saivin, Sylvie, Saint-Marcoux, Franck, Royer-Morrot, Marie-Jose, Royer, Bernard, Rousseau, Annick, Poirier, Jean-Marie, Parant, Francois, Palette, Catherine, Paintaud, Gilles, Muret, Patrice, Monjanel-Mouterde, Suzanne, Monchaud, Caroline, Molimard, Mathieu, Mentre, France, Mathieu, Olivier, Marquet, Pierre, Loichot, Cecile, Libert, Frederic, Lemaire-Hurtel, Anne-Sophie, Lelong-Boulouard, Veronique, Lefeuvre, Sandrine, Laporte, Silvy, Lacarelle, Bruno, Jullien, Vincent, Jacqz-Aigrain, Evelyne, Hulot, Jean-Sebastien, Hulin, Anne, Hoizey, Guillaume, Hillaire-Buys, Dominique, Gozalo, Claire, Goirand, Francoise, Garraffo, Rodolphe, Gambier, Nicolas, Gagnieu, Marie-Claude, Furlan, Valerie, Fonrose, Xavier, Eschalier, Alain, Djerada, Zoubir, Diquet, Bertrand, Delhotal-Landes, Brigitte, Debruyne, Daniele, Dailly, Eric, Couet, William, Compagnon, Patricia, Comets, Emmanuelle, Chhun, Stephanie, Chatelut, Etienne, Camus, Maryse, Boyer, Jean-Christophe, Boulieu, Roselyne, Boulamery, Audrey, Bouchet, Stephane, Boisson, Mireille, Boisdron-Celle, Michele, Billaud, Eliane, Becquemont, Laurent, Basset, Thierry, Barrail-Tran, Aurelie, Alvarez, Jean-Claude, Abe, Emuri, groupe STP de la SFPT, Bentue-Ferrer, Daniele, Le Guellec, Chantal, Therapie, 2010

Relative quantitative proteomic analysis of CNI-induced toxicity in a porcine proximal tubule cell line using iTRAQ technique, Essig, Marie, Marquet, Pierre, Gonzalez, Julien, Pinault, Emilie, Burat, Bastien, Acta Physiologica, 2016

[Perinatal pharmacology of opiates]., Marquet, P, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2000, 10.1016/S0929-693X(00)80074-3

Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: A collaborative study, Seguela, JP, Vest, P, Renaudeau, C, Pelissier, AL, Mathe, D, Lhermitte, M, Guery, B, Garnier, M, Facy, F, Bremond, J, Kerguelen, S, Delpla, PA, Marquet, P, Journal of Forensic Sciences, 1998

Ribavirin: Past, present and future., Carrier, Paul, Rousseau, Annick, Sautereau, Denis, Marquet, Pierre, Alain, Sophie, Jacques, Jeremie, Debette-Gratien, Marilyne, Loustaud-Ratti, Veronique, World journal of hepatology, 2016, 10.4254/wjh.v8.i2.123

Development of a Bayesian estimator based on limited sampling strategies for Advagraf (R) and Prograf (R) in de novo adult liver transplant patients, Woillard, J. B., Marquet, P., Debord, J., Riff, C., Fundamental & Clinical Pharmacology, 2017

ACOUSTIC PROPERTIES OF THE NORMAL CHEST, MENIER, R, MARQUET, P, ANTONINI, MT, DALMAY, F, European Respiratory Journal, 1995, 10.1183/09031936.95.08101761

The Effect of Genetic Variations in Cytochromes P450 3A, the P450 Oxydoreductase (POR) and the Nuclear Receptor PPARA on Sirolimus In Vitro Metabolism, Trough Levels and Adverse Events in Kidney Transplant Recipients, Picard, N., Marquet, P., Rostaing, L., Coste, S., Kamar, N., Woillard, J. B., Therapeutic Drug Monitoring, 2013

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies, Rousseau, A., Essig, M., Marquet, P., Munteanu, E., Buchler, M., Thierry, A., Gatault, P., Filloux, M., Premaud, A., Plos One, 2017, 10.1371/journal.pone.0180236

Relationship between psychotropic drugs and thyroid function: A review, Lachatre, G, Buxeraud, J, Raby, C, Rousseau, A, Marquet, P, Sauvage, MF, Toxicology and Applied Pharmacology, 1998, 10.1006/taap.1998.8367

Optimization of Vancomycin Initial Dose in Term and Preterm Neonates by Machine Learning., Woillard JB, Jacqz-Aigrain E, Labriffe M, Marquet P, Destere A, Ensuque P, Ponthier L, Pharmaceutical research, 2022, 10.1007/s11095-022-03351-6

First 6-month report of the longitudinal PHACS study (Pharmacology and Hormonotherapy (HT) for Adjuvant breast Cancer (BC) Study, NCT01127295), Filleron, T., Chatelut, E., Evrard, A., Marquet, P., Pinguet, F., Robert, J., Mauries, V., Massabeau, C., Lavau-Denes, S., Laharie-Mineur, H., Ferrer, C., Franck, D., Dohollou, N., Molnar-Stanciu, D., Dalenc, F., Suc, E., Jacot, W., Debled, M., Venat-Bouvet, L., Roche, H., Cancer Research, 2018

Quality control in therapeutic survey, Asqualab 1997-1999, Vassault, A, Roux, A, Marquet, P, Palette, C, Morel, I, Anglard, I, Feuillu, A, Annales De Biologie Clinique, 2000

Rheumatoid Factor Interference in a Tacrolimus Immunoassay, Fortuny Marques, Regina, Riesco Prieto, Maria, Barcelo Bennasar, Antonia, Castanyer Puig, Bartomeu, Maria Ferrer, Joana, Marquet, Pierre, Barcelo Martin, Bernardi, Therapeutic Drug Monitoring, 2009

Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients, Jean Debord, Jean-Baptiste Woillard, Nicolas Picard, Antoine Thierry, Isabelle Etienne, Hakim Mazouz, Matthias Buchler, Jean-Philippe Rérolle, Caroline Monchaud, Alexandre Destère, Pierre Marquet, Clinical Pharmacokinetics, 2021, 10.1007/s40262-020-00959-y

STEROID-FREE REGIMEN AND OPTIMIZATION OF MYCOPHENOLIC ACID (MPA) EXPOSURE IN LIVER TRANSPLANT RECIPIENTS: FINAL RESULTS OF CELLESTE, Rostaing, Lionel, Taguieva, Naila, Dur, Carole, Marquet, Pierre, Vanlemmens, Claire, Hardwigsen, Jean, Dharancy, Sebastien, Pageaux, Georges-Philippe, Duvoux, Christophe, Altieri, Mario, Calmus, Yvon, Neau-Cransac, Martine, Leroy, Vincent, Radenne, Sylvie, Gugenheim, Jean, Durand, Francois, Saliba, Faouzi, Transplant International, 2012

MPA EXPOSURE IN PATIENTS WITH EARLY STEROID WITHDRAWAL: COMPARISON BETWEEN TWO MMF BASED IMMUNOSUPPRESSIVE REGIMENS, CONCENTRATION-CONTROLLED VERSUS FIXED DOSE, Marquet, P., Tagieva, N., Rouanet, S., Thervet, E., Dantal, J., Bayle, F., Vrtovsnik, F., Mousson, C., Glotz, D., Kessler, M., Lebranchu, Y., Tricot, L., Rondeau, E., Kamar, N., Le Meur, Y., Transplant International, 2009

Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach., , British journal of clinical pharmacology, 2019, 10.1111/bcp.14110

POPULATION PHARMACOKINETICS OF AMIKACIN IN INTENSIVE-CARE UNIT PATIENTS STUDIED BY NPEM ALGORITHM, LACHSATRE, G, MERLE, L, LOTFI, H, MARQUET, P, VOULTOURY, JC, PESSIS, C, DEBORD, J, Fundamental & Clinical Pharmacology, 1995

Effects of Calcineurin Inhibitors and Implication of Efflux Transporters and CYP3A on the Intestinal Flux of mTOR Inhibitors, Marquet, P., Sauvage, F. L., Picard, N., Lamoureux, F., Therapeutic Drug Monitoring, 2009

[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects]., Verstuyft, C, Watier, H, Picard, N, Peoc'h, K, Paintaud, G, Namour, B, Morel, A, Marquet, P, Loriot, M-A, Loric, S, Jacqz-Aigrain, E, Goze, C, Gamelin, E, Gagnieu, M-C, Fonrose, X, Dhaneens, C-M, Broly, F, Boyer, J-C, Boisdron-Celle, M, Bezieau, S, Bessard, G, Becquemont, L, Beaune, P-H, Allorge, D, Annales pharmaceutiques francaises, 2007, 10.1016/S0003-4509(07)74196-2

A Chinese cream (Fu Suo) for psoriasis, Marquet, P, Bonnetblanc, JM, Dermatology, 1996

Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?, Marquet P, Labriffe M, Saint-Marcoux F, Monchaud C, Woillard JB, Transplantation, 2022, 10.1097/tp.0000000000004405

Population pharmacokinetic modeling of oral cyclosporin using NONMEM - Comparison of absorption pharmacokinetic models and design of a Bayesion estimator, Marquet, P, Buchler, M, Paintaud, G, Saint-Marcoux, F, Le Meur, Y, Leger, F, Rousseau, A, Therapeutic Drug Monitoring, 2004, 10.1097/00007691-200402000-00006

Foreseeable advantages and limits of buprenorphine-naloxone association, Marquet, P, Kintz, P, Gatignol, C, Barjhoux, CE, Villier, C, Dematteis, M, Mallaret, M, Buprenorphine Therapy of Opiate Addiction, 2002

Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus, Verbeeck, Roger K., Wallemacq, Pierre, Marquet, Pierre, Cumps, Jean, Senessael, Jean-Jacques, Bosmans, Jean-Louis, Rousseau, Annick, Musuamba, Flora T., Clinical Pharmacokinetics, 2009

LOOKING FOR CYCLOSPORINE AUC TARGETS IN RENAL TRANSPLANTATION, Marquet, P., Essig, M., Rerolle, J. P., Woillard, J. B., Saint-Marcoux, F., Beaurain, M., Transplant International, 2013

Determination of colchicine in biological fluids by liquid chromatography mass spectrometry with pneumatically assisted electrospray ionization., Lachatre, G, Dreyfuss, MF, Dupuy, JL, Lotfi, H, Verneuil, B, Marquet, P, Hoja, H, Analusis, 1996

FP7 BIOMARGIN: URINARY PROTEIN BIOMARKERS OF RENAL GRAFT INJURIES IN KIDNEY ALLOGRAFT RECIPIENTS, Mertens, I., Marquet, P., Essig, M., Anglicheau, D., Gwinner, W., Naesens, M., Baggerman, G., Schildermans, K., Willems, H., Transplant International, 2017

In vitro metabolism study of buprenorphine: Evidence for new metabolic pathways, Marquet, P, Djebli, N, Cresteil, T, Picard, N, Drug Metabolism and Disposition, 2005, 10.1124/dmd.105.003681

Metabolic interactions of benzodiazepines with oxycodone ex vivo and toxicity depending on usage patterns in an animal model., El Balkhi S, Saint-Marcoux F, Marquet P, Picard N, Trouillas P, Otyepka M, Bazgier V, Javellaud J, Zarrouk E, Čechová P, Lawson R, British journal of pharmacology, 2022, 10.1111/bph.15765

Cost-effectiveness of mycophenolate mofetil monitoring and dose adjustment in kidney transplant recipients, Le Meur, Y., Hoizey, G., Compagnon, P., Hary, L., Venisse, N., Grima, M., Turcant, A., Debruyne, D., Saivin, S., Jacqz-Aigrain, E., Vergnenegre, A., Marquet, P., Laroche, M. L., Fundamental & Clinical Pharmacology, 2007

Découvrez nos professeurs et professeures!

Pierre Marquet

Contribution à la recherche

Axe de recherche de l'Université Laval :

Santé et bien-être durables

Thématiques de recherche de la Faculté de médecine :

Neurosciences et santé mentale

Domaines et intérêts de recherche du (de la) professeur(e) :

Neurosciences, santé mentale et toxicomanies

Individu

Famille

Cellulaire

Subcellulaire

Organismes vivants (êtres humains - Psychologie/aspects biologiques)

Outils de caractérisation

Intelligence artificielle

Projets de recherche

Publications

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Encadrement d'étudiant(e)s pour les programmes suivants :

Biologie cellulaire et moléculaire

Médecine moléculaire

Neurobiologie — Neurosciences

Sciences cliniques et biomédicales

Disponibilité d'encadrement d'étudiant(e)s

Direction et personnes-ressources